Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Deepak L. Bhatt, M.D.

TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Women's Hospital
Director Interventional Cardio Prog / SH-5150
75 Francis St
Boston MA 02115
Phone857/307-1992
Fax857/307-1955
vCardDownload vCard (login for email)
Other Positions
TitleEditor, Harvard Heart Letter
InstitutionHarvard Medical School
DepartmentHarvard Health Publications


 Biography 
 awards and honors
2008 - Distinguished Faculty Award for Excellence in Research Mentorship
2009 - Anandi L. Sharma Visiting Professorship
2009 - Simon Dack Award for Outstanding Scholarship
2010 - Cardiovascular Fellows’ Visiting Professor
2010 - Elected Member
2012 - Greenfield Visiting Professor of Medicine
2012 - Visiting Professor in Vascular Medicine

 Overview 
 overview
Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC, is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart and Vascular Center and Professor of Medicine at Harvard Medical School. He is also a Senior Physician at Brigham and Women’s Hospital and a Senior Investigator in the TIMI Study Group.

After graduating as valedictorian from the Boston Latin School, Dr. Bhatt obtained his undergraduate science degree as a National Merit Scholar at the Massachusetts Institute of Technology while also serving as a research associate at Harvard Medical School. He received his medical doctorate from Cornell University. He completed a Masters in Public Health with a concentration in clinical effectiveness at Harvard University. His internship and residency in internal medicine were performed at the Hospital of the University of Pennsylvania, and his cardiovascular training was completed at Cleveland Clinic. He also completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention as well as serving as Chief Interventional Fellow at Cleveland Clinic where he spent several years as an interventional cardiologist and an Associate Professor of Medicine. He served for many years as Director of the Interventional Cardiology Fellowship and as Associate Director of the Cardiovascular Medicine Fellowship. He also served as Associate Director of the Cleveland Clinic Cardiovascular Coordinating Center. He was then recruited to be the Chief of Cardiology at VA Boston Healthcare System where he served for several years. Dr. Bhatt was listed in Best Doctors in America from 2005 to 2014. He was selected by Brigham and Women’s Hospital as the 2014 Eugene Braunwald Scholar.

Dr. Bhatt’s research interests include acute coronary syndromes, preventive cardiology, and advanced techniques in cardiac, cerebral, and peripheral intervention. He has authored or co-authored over 700 publications and is listed as a Thomson Reuters Highly Cited Researcher. He is the editor of Atherothrombosis in Clinical Practice published by Oxford University Press and of Peripheral and Cerebrovascular Intervention published by Springer. He was the international PI for the CHARISMA and CRESCENDO trials and co-PI of the three CHAMPION trials. He served as chair of COGENT and helped lead STAMPEDE. He serves as co-chair of the REACH registry and chairs REDUCE-IT. He is co-PI of SAVOR-TIMI 53, SYMPLICITY HTN-3, and THEMIS. He is the current Chair of the AHA-GWTG Steering Committee. He is Senior Associate Editor for News and Clinical Trials for ACC.org. Dr. Bhatt has been a visiting lecturer at a number of prestigious institutions throughout the world. He has been interviewed extensively by news agencies on numerous topics. He is the Editor of the peer-reviewed Journal of Invasive Cardiology, Chief Medical Editor of Cardiology Today’s Intervention for healthcare professionals, and Editor-in-Chief of the Harvard Heart Letter for patients.


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Depta JP, Bhatt DL. New approaches to inhibiting platelets and coagulation. Annu Rev Pharmacol Toxicol. 2015 Jan 6; 55:373-97.
    View in: PubMed
  2. Dudzinski DM, Bhatt DL, Aragam JR, Maron BA. Explaining unexplained dyspnea: the ever "holesome" heart. Circulation. 2014 Dec 2; 130(23):2057-66.
    View in: PubMed
  3. Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, Patel MR, Sandhu A, Valle J, Magid DJ, Leon B, Bhatt DL, Fihn SD, Rumsfeld JS. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014 Nov 5; 312(17):1754-63.
    View in: PubMed
  4. Bavry AA, Kapadia SR, Bhatt DL, Kumbhani DJ. Renal Artery Revascularization: Updated Meta-analysis With the CORAL Trial. JAMA Intern Med. 2014 Nov 1; 174(11):1849-51.
    View in: PubMed
  5. Lytle BL, Li S, Lofthus DM, Thomas L, Poteat JL, Bhatt DL, Cannon CP, Fonarow GC, Peterson ED, Wang TY, Alexander KP. Targeted versus standard feedback: Results from a Randomized Quality Improvement Trial. Am Heart J. 2015 Jan; 169(1):132-141.e2.
    View in: PubMed
  6. Mahfoud F, Tunev S, Ruwart J, Schulz-Jander D, Cremers B, Linz D, Zeller T, Bhatt DL, Rocha-Singh K, Böhm M, Melder RJ. Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries. Circ Cardiovasc Interv. 2014 Dec; 7(6):813-20.
    View in: PubMed
  7. Vivo RP, Krim SR, Liang L, Neely M, Hernandez AF, Eapen ZJ, Peterson ED, Bhatt DL, Heidenreich PA, Yancy CW, Fonarow GC. Short- and Long-term Rehospitalization and Mortality for Heart Failure in 4 Racial/Ethnic Populations. J Am Heart Assoc. 2014; 3(5).
    View in: PubMed
  8. Rubboli A, Faxon DP, Juhani Airaksinen KE, Schlitt A, Marín F, Bhatt DL, Lip GY. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview. Thromb Haemost. 2014 Dec 1; 112(6):1080-7.
    View in: PubMed
  9. Tremmel JA, Patel RA, Bhatt DL, Cilingiroglu M, Pinto DS, Dean LS, Grines CL. Commentary on highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013. Catheter Cardiovasc Interv. 2015 Jan 1; 85(1):95-103.
    View in: PubMed
  10. Bangalore S, Bhatt DL, Steg PG, Weber MA, Boden WE, Hamm CW, Montalescot G, Hsu A, Fox KA, Lincoff AM. ß-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction: Post Hoc Analysis From the CHARISMA Trial. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):872-81.
    View in: PubMed
  11. Ovbiagele B, Smith EE, Schwamm LH, Grau-Sepulveda MV, Saver JL, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC. Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):929-35.
    View in: PubMed
  12. Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM. Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs: An Evaluation of the ClinicalTrials.gov Database. Circulation. 2014 Nov 11; 130(20):1812-9.
    View in: PubMed
  13. Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery. Diabetes Obes Metab. 2014 Dec; 16(12):1230-8.
    View in: PubMed
  14. Xian Y, Holloway RG, Smith EE, Schwamm LH, Reeves MJ, Bhatt DL, Schulte PJ, Cox M, Olson DM, Hernandez AF, Lytle BL, Anstrom KJ, Fonarow GC, Peterson ED. Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage. Stroke. 2014 Nov; 45(11):3243-50.
    View in: PubMed
  15. Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, Davidson J, Steg PG, Bhatt DL. Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial. Circulation. 2014 Oct 28; 130(18):1579-88.
    View in: PubMed
  16. Bhatt DL. Ask the doctor. My lower legs tend to swell when I take long plane trips. Would compression stockings help? Harv Heart Lett. 2014 Sep; 25(1):2.
    View in: PubMed
  17. Bhatt DL. Ask the doctor. After several episodes where my heart suddenly started racing, I was diagnosed with supraventricular tachycardia. My doctor said I could try gagging or coughing to help slow down my heart when these episodes occur. Why would these things help? Harv Heart Lett. 2014 Sep; 25(1):2.
    View in: PubMed
  18. Abtan J, Elbez Y, Bhatt DL, Steg PG. Lack of negative interaction between use of Beta-blockers and statins on cardiovascular outcomes among patients with or at risk for atherothrombosis. J Am Coll Cardiol. 2014 Aug 26; 64(8):845-7.
    View in: PubMed
  19. Ovbiagele B, Schwamm LH, Smith EE, Grau-Sepulveda MV, Saver JL, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC. Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes. J Stroke Cerebrovasc Dis. 2014 Oct; 23(9):2265-73.
    View in: PubMed
  20. Walia HK, Li H, Rueschman M, Bhatt DL, Patel SR, Quan SF, Gottlieb DJ, Punjabi NM, Redline S, Mehra R. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J Clin Sleep Med. 2014; 10(8):835-43.
    View in: PubMed
  21. Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med. 2014 Aug 14; 371(7):682.
    View in: PubMed
  22. Cronin CA, Sheth KN, Zhao X, Messé SR, Olson DM, Hernandez AF, Bhatt DL, Schwamm LH, Smith EE. Adherence to third European cooperative acute stroke study 3- to 4.5-hour exclusions and association with outcome: data from get with the guidelines-stroke. Stroke. 2014 Sep; 45(9):2745-9.
    View in: PubMed
  23. Schwartz GG, Bessac L, Berdan LG, Bhatt DL, Bittner V, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Rorick T, Sasiela WJ, Shirodaria C, Szarek M, Tamby JF, Tricoci P, White H, Zeiher A, Steg PG. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial. Am Heart J. 2014 Nov; 168(5):682-689.e1.
    View in: PubMed
  24. Bangalore S, Singh A, Toklu B, DiNicolantonio JJ, Croce K, Feit F, Bhatt DL. Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials. Open Heart. 2014; 1(1):e000068.
    View in: PubMed
  25. Bagai A, Wang Y, Wang TY, Curtis JP, Gurm HS, Shah B, Cheema AN, Peterson ED, Saucedo JF, Granger CB, Roe MT, Bhatt DL, McNamara RL, Alexander KP. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. Circ Cardiovasc Interv. 2014 Aug; 7(4):585-93.
    View in: PubMed
  26. Bhatt DL. New section launched in clinical cardiology!: submit today for the clinical trial updates section. Clin Cardiol. 2014 Aug; 37(8):455.
    View in: PubMed
  27. Sarode K, Spelber DA, Bhatt DL, Mohammad A, Prasad A, Brilakis ES, Banerjee S. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease. JACC Cardiovasc Interv. 2014 Aug; 7(8):827-39.
    View in: PubMed
  28. Bhatt DL. Ask the doctor. I have been taking a heart rhythm medicine to treat my atrial fibrillation. However, it is not working very well. Should I consider a catheter ablation procedure or try other medicines first? Harv Heart Lett. 2014 Aug; 24(12):2.
    View in: PubMed
  29. Bhatt DL. Ask the doctor. My family doctor heard a heart murmur and sent me to a cardiologist, who diagnosed aortic valve sclerosis after doing an echocardiogram. Should I worry? Harv Heart Lett. 2014 Aug; 24(12):2.
    View in: PubMed
  30. Khera S, Kolte D, Aronow WS, Palaniswamy C, Subramanian KS, Hashim T, Mujib M, Jain D, Paudel R, Ahmed A, Frishman WH, Bhatt DL, Panza JA, Fonarow GC. Non-ST-Elevation Myocardial Infarction in the United States: Contemporary Trends in Incidence, Utilization of the Early Invasive Strategy, and In-Hospital Outcomes. J Am Heart Assoc. 2014; 3(4).
    View in: PubMed
  31. Cheng RK, Cox M, Neely ML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J. 2014 Nov; 168(5):721-730.e3.
    View in: PubMed
  32. White WB, Turner JR, Sica DA, Bisognano JD, Calhoun DA, Townsend RR, Aronow HD, Bhatt DL, Bakris GL. Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013. J Am Soc Hypertens. 2014 Oct; 8(10):743-57.
    View in: PubMed
  33. Khalili H, Patel VG, Mayo HG, de Lemos JA, Brilakis ES, Banerjee S, Bavry AA, Bhatt DL, Kumbhani DJ. Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST-Segment elevation myocardial infarction: A meta-analysis of 15 randomized trials. Catheter Cardiovasc Interv. 2014 Nov 15; 84(6):978-86.
    View in: PubMed
  34. Bhatt DL, Bakris GL. Renal denervation for resistant hypertension. N Engl J Med. 2014 Jul 10; 371(2):184.
    View in: PubMed
  35. Bhatt DL, Cavender MA. Do dipeptidyl peptidase-4 inhibitors increase the risk of heart failure? JACC Heart Fail. 2014 Dec; 2(6):583-5.
    View in: PubMed
  36. Bhatt DL. What does the future hold for renal denervation? Eur Heart J. 2014 Jul; 35(26):1695-6.
    View in: PubMed
  37. Bhatt DL. Ask the doctor. What's the difference between atrial flutter and atrial fibrillation? Harv Heart Lett. 2014 Jul; 24(11):2.
    View in: PubMed
  38. Bhatt DL. Ask the doctor. I've heard that taking statins can raise your risk of diabetes. Is this really true? Harv Heart Lett. 2014 Jul; 24(11):2.
    View in: PubMed
  39. Mehta RH, Cox M, Smith EE, Xian Y, Bhatt DL, Fonarow GC, Peterson ED. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy. Stroke. 2014 Aug; 45(8):2263-9.
    View in: PubMed
  40. Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF, Babineau DC, Tracy RP, Rueschman M, Blumenthal RS, Lewis EF, Bhatt DL, Redline S. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014 Jun 12; 370(24):2276-85.
    View in: PubMed
  41. Raz I, Bhatt DL, Hirshberg B, Mosenzon O, Scirica BM, Umez-Eronini A, Im K, Stahre C, Buskila A, Iqbal N, Greenberger N, Lerch MM. Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin. Diabetes Care. 2014 Sep; 37(9):2435-41.
    View in: PubMed
  42. Eapen ZJ, Liang L, Shubrook JH, Bauman MA, Bufalino VJ, Bhatt DL, Peterson ED, Hernandez AF. Current quality of cardiovascular prevention for Million Hearts: An analysis of 147,038 outpatients from The Guideline Advantage. Am Heart J. 2014 Sep; 168(3):398-404.
    View in: PubMed
  43. Byrd JB, Maddox TM, O'Donnell CI, Grunwald GK, Bhatt DL, Tsai TT, Rumsfeld JS, Ho PM. Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: Insights from the Veterans Affairs CART Program. Am Heart J. 2014 Sep; 168(3):340-5.
    View in: PubMed
  44. Bhatt DL, Hulot JS, Moliterno DJ, Harrington RA. Antiplatelet and anticoagulation therapy for acute coronary syndromes. Circ Res. 2014 Jun 6; 114(12):1929-43.
    View in: PubMed
  45. Ovbiagele B, Schwamm LH, Smith EE, Grau-Sepulveda MV, Saver JL, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC. Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease. J Am Heart Assoc. 2014; 3(3).
    View in: PubMed
  46. Bhatt DL. Ask the doctor. Is it okay to eat leafy greens while taking warfarin? I was surprised to see spinach and kale recommended as "superfoods" for heart health in your March issue. I take Coumadin for atrial fibrillation and have been told to avoid green leafy vegetables. I had always enjoyed these foods in the past, so I'd be glad to know if it's okay to eat them. Harv Heart Lett. 2014 Jun; 24(10):2.
    View in: PubMed
  47. Bhatt DL. Ask the doctor. What is Prinzmetal's angina? A doctor recently told my wife that she might have Prinzmetal's angina. What is this condition, and how is it treated? Harv Heart Lett. 2014 Jun; 24(10):2.
    View in: PubMed
  48. Kumbhani DJ, Bavry AA, Desai MY, Bangalore S, Byrne RA, Jneid H, Bhatt DL. Aspiration thrombectomy in patients undergoing primary angioplasty: Totality of data to 2013. Catheter Cardiovasc Interv. 2014 Nov 15; 84(6):973-7.
    View in: PubMed
  49. Gutierrez A, Bhatt DL. Balancing the risks of stent thrombosis and major bleeding during primary percutaneous coronary intervention. Eur Heart J. 2014 Sep 21; 35(36):2448-51.
    View in: PubMed
  50. Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL. Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure: Results From SYMPLICITY HTN-3. J Am Coll Cardiol. 2014 Sep 16; 64(11):1071-8.
    View in: PubMed
  51. Setoguchi S, Warner Stevenson L, Stewart GC, Bhatt DL, Epstein AE, Desai M, Williams LA, Chen CY. Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure. BMJ. 2014; 348:g2866.
    View in: PubMed
  52. Bhatt DL. Ask the doctor. I check my blood pressure at home regularly. My readings are all over the place and different from the reading at my most recent doctor visit. Why is my blood pressure so erratic? Harv Heart Lett. 2014 May; 24(9):2.
    View in: PubMed
  53. Bhatt DL. Ask the doctor. I have been taking a statin to bring down my LDL cholesterol, but my HDL is still on the low side. Do I need to worry about my HDL level if my LDL is okay? If so, what should I do? Harv Heart Lett. 2014 May; 24(9):2.
    View in: PubMed
  54. Tremmel JA, Patel RA, Bhatt DL, Cilingiroglu M, Pinto DS, Dean LS, Grines CL. Commentary on late breaking trials in interventional cardiology at ESC, VIVA, TCT, AHA (Fall 2012), and ACC 2013. Catheter Cardiovasc Interv. 2014 May 1; 83(6):936-43.
    View in: PubMed
  55. Timur AA, Murugesan G, Zhang L, Barnard J, Bhatt DL, Kottke-Marchant K. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy. Thromb Res. 2014 Jul; 134(1):96-104.
    View in: PubMed
  56. Bangalore S, Bhatt DL. Embolic protection devices. Circulation. 2014 Apr 29; 129(17):e470-6.
    View in: PubMed
  57. Ademi Z, Liew D, Gorelik A, Bohensky M, Zomer E, Hollingsworth B, Steg G, Bhatt DL, Reid CM. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data. Int J Cardiol. 2014 Jul 15; 175(1):72-7.
    View in: PubMed
  58. Feres F, Costa RA, Bhatt DL. Dual antiplatelet therapy after stent implantation-reply. JAMA. 2014 Apr 9; 311(14):1446-7.
    View in: PubMed
  59. Xian Y, Smith EE, Zhao X, Peterson ED, Olson DM, Hernandez AF, Bhatt DL, Saver JL, Schwamm LH, Fonarow GC. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. Stroke. 2014 May; 45(5):1387-95.
    View in: PubMed
  60. Shen L, Shah BR, Nam A, Holmes D, Alexander KP, Bhatt DL, Ho PM, Peterson ED, He B, Roe MT. Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction. Am Heart J. 2014 Jun; 167(6):840-5.
    View in: PubMed
  61. Fonarow GC, Zhao X, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Xian Y, Hernandez AF, Peterson ED, Schwamm LH. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2014 Apr 23-30; 311(16):1632-40.
    View in: PubMed
  62. Bhatt DL. Ask the doctor. I am a 71-year-old man with high blood pressure, and I smoked for many years. Should I be tested for an abdominal aortic aneurysm? Harv Heart Lett. 2014 Apr; 24(8):2.
    View in: PubMed
  63. Bhatt DL. Ask the doctor. I'm a cancer survivor and take a calcium-channel blocker for high blood pressure. I recently read that these medications can cause cancer. But it's the only drug that's worked well for me. Should I stop taking it? Harv Heart Lett. 2014 Apr; 24(8):2.
    View in: PubMed
  64. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014 May 22; 370(21):2002-13.
    View in: PubMed
  65. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014 Apr 10; 370(15):1393-401.
    View in: PubMed
  66. Bangalore S, Schwamm L, Smith EE, Singh IM, Liang L, Fonarow GC, Bhatt DL. Secondary prevention after ischemic stroke or transient ischemic attack. Am J Med. 2014 Aug; 127(8):728-38.
    View in: PubMed
  67. Goldstein S, Bates ER, Bhatt DL, Cao C, Holmes D, Kupfer S, Martinez F, Spaeder J, Weitz JI, Ye Z, Zannad F. Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome. Thromb Haemost. 2014 Jun 2; 111(6):1141-52.
    View in: PubMed
  68. Zenati MA, Gaziano JM, Collins JF, Biswas K, Gabany JM, Quin JA, Bitondo JM, Bakaeen FG, Kelly RF, Shroyer AL, Bhatt DL. Choice of Vein-Harvest Technique for Coronary Artery Bypass Grafting: Rationale and Design of the REGROUP Trial. Clin Cardiol. 2014 Jun; 37(6):325-30.
    View in: PubMed
  69. Sun CH, Bhatt DL, Nogueira RG, Gupta R. Endovascular therapy for stroke: getting to the "heart" of the matter. Circulation. 2014 Mar 11; 129(10):1152-60.
    View in: PubMed
  70. Sorbets E, Labreuche J, Simon T, Delorme L, Danchin N, Amarenco P, Goto S, Meune C, Eagle KA, Bhatt DL, Steg PG. Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure. Eur Heart J. 2014 Jul 7; 35(26):1760-8.
    View in: PubMed
  71. Cavender MA, Rassi AN, Schwamm LH, Fonarow GC, Cannon CP, Peacock WF, Laskey WK, Hernandez AF, Peterson ED, Cox M, Grau-Sepulveda M, Bhatt DL. Authors' reply. Clin Cardiol. 2014 May; 37(5):323.
    View in: PubMed
  72. Bhatt DL. Ask the doctor. The June 2013 issue states on page 3 that "it's important to increase potassium intake, particularly if you take a diuretic." But on page 5, it says that if you take spironolactone (which I do), you should avoid high-potassium foods. I'm confused--should I be eating bananas and other potassium-rich foods or not? Harv Heart Lett. 2014 Mar; 24(7):2.
    View in: PubMed
  73. Bhatt DL. Ask the doctor. I was having occasional chest pains, and my primary care physician recommended a stress test. Because I have bad knees, the cardiologist had me take a stress test using a medication instead of doing exercise. Fortunately, the results were normal. But it made me wonder: is one type better than the other? Harv Heart Lett. 2014 Mar; 24(7):2.
    View in: PubMed
  74. Vemulapalli S, Ard J, Bakris GL, Bhatt DL, Brown AS, Cushman WC, Ferdinand KC, Flack JM, Fleg JL, Katzen BT, Kostis JB, Oparil S, Patel CB, Pepine CJ, Piña IL, Rocha-Singh KJ, Townsend RR, Peterson ED, Califf RM, Patel MR. Proceedings from duke resistant hypertension think tank. Am Heart J. 2014 Jun; 167(6):775-788.e1.
    View in: PubMed
  75. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014 Nov 1; 35(41):2864-72.
    View in: PubMed
  76. Mahaffey KW, Wojdyla DM, Pieper KS, Tricoci P, Alexander JH, Lincoff AM, Brennan DM, Bhatt DL, Wallentin L, Harrington RA. Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis. Clin Cardiol. 2014 Jun; 37(6):337-42.
    View in: PubMed
  77. Bainey KR, Armstrong PW, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Zhao X, Schwamm LH, Bhatt DL. Use of Renin-Angiotensin system blockers in acute coronary syndromes: findings from get with the guidelines-coronary artery disease program. Circ Cardiovasc Qual Outcomes. 2014 Mar 1; 7(2):227-35.
    View in: PubMed
  78. Tragante V, Barnes MR, Ganesh SK, Lanktree MB, Guo W, Franceschini N, Smith EN, Johnson T, Holmes MV, Padmanabhan S, Karczewski KJ, Almoguera B, Barnard J, Baumert J, Chang YP, Elbers CC, Farrall M, Fischer ME, Gaunt TR, Gho JM, Gieger C, Goel A, Gong Y, Isaacs A, Kleber ME, Mateo Leach I, McDonough CW, Meijs MF, Melander O, Nelson CP, Nolte IM, Pankratz N, Price TS, Shaffer J, Shah S, Tomaszewski M, van der Most PJ, Van Iperen EP, Vonk JM, Witkowska K, Wong CO, Zhang L, Beitelshees AL, Berenson GS, Bhatt DL, Brown M, Burt A, Cooper-Dehoff RM, Connell JM, Cruickshanks KJ, Curtis SP, Davey-Smith G, Delles C, Gansevoort RT, Guo X, Haiqing S, Hastie CE, Hofker MH, Hovingh GK, Kim DS, Kirkland SA, Klein BE, Klein R, Li YR, Maiwald S, Newton-Cheh C, O'Brien ET, Onland-Moret NC, Palmas W, Parsa A, Penninx BW, Pettinger M, Vasan RS, Ranchalis JE, M Ridker P, Rose LM, Sever P, Shimbo D, Steele L, Stolk RP, Thorand B, Trip MD, van Duijn CM, Verschuren WM, Wijmenga C, Wyatt S, Young JH, Zwinderman AH, Bezzina CR, Boerwinkle E, Casas JP, Caulfield MJ, Chakravarti A, Chasman DI, Davidson KW, Doevendans PA, Dominiczak AF, Fitzgerald GA, Gums JG, Fornage M, Hakonarson H, Halder I, Hillege HL, Illig T, Jarvik GP, Johnson JA, Kastelein JJ, Koenig W, Kumari M, März W, Murray SS, O'Connell JR, Oldehinkel AJ, Pankow JS, Rader DJ, Redline S, Reilly MP, Schadt EE, Kottke-Marchant K, Snieder H, Snyder M, Stanton AV, Tobin MD, Uitterlinden AG, van der Harst P, van der Schouw YT, Samani NJ, Watkins H, Johnson AD, Reiner AP, Zhu X, de Bakker PI, Levy D, Asselbergs FW, Munroe PB, Keating BJ. Gene-centric Meta-analysis in 87,736 Individuals of European Ancestry Identifies Multiple Blood-Pressure-Related Loci. Am J Hum Genet. 2014 Mar 6; 94(3):349-60.
    View in: PubMed
  79. Kumbhani DJ, Bavry AA, Desai MY, Bangalore S, Bhatt DL. Reply: aspiration thrombectomy: an easily forgiven "latecomer". J Am Coll Cardiol. 2014 May 20; 63(19):2053.
    View in: PubMed
  80. Bhatt DL. Clopidogrel and proton pump inhibitors. CMAJ. 2014 Feb 18; 186(3):213.
    View in: PubMed
  81. Seif F, Patel SR, Walia HK, Rueschman M, Bhatt DL, Blumenthal RS, Quan SF, Gottlieb DJ, Lewis EF, Patil SP, Punjabi NM, Babineau DC, Redline S, Mehra R. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk. J Hypertens. 2014 Feb; 32(2):267-75.
    View in: PubMed
  82. Bhatt DL. Ask the doctor. I've noticed my belly getting larger in the last five years or so. I walk about half a mile every day and lift weights twice a week. I've cut back on big meals, but nothing gets rid of the belly fat. Harv Heart Lett. 2014 Feb; 24(6):2.
    View in: PubMed
  83. Bhatt DL. Ask the doctor. Is CPR safe for a person who has had coronary bypass surgery or who has a stent in place? Harv Heart Lett. 2014 Feb; 24(6):2.
    View in: PubMed
  84. Vardi M, Debidda M, Bhatt DL, Mauri L, Cannon CP. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists. Clin Cardiol. 2014 Feb; 37(2):103-7.
    View in: PubMed
  85. Allen LA, Fonarow GC, Grau-Sepulveda MV, Hernandez AF, Peterson PN, Partovian C, Li SX, Heidenrich PA, Bhatt DL, Peterson ED, Krumholz HM. Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from get with the guidelines. Circ Heart Fail. 2014 Mar 1; 7(2):251-60.
    View in: PubMed
  86. Scirica BM, Braunwald E, Bhatt DL. Saxagliptin, alogliptin, and cardiovascular outcomes. N Engl J Med. 2014 Jan 30; 370(5):483-4.
    View in: PubMed
  87. Bakaeen FG, Zenati MA, Bhatt DL. Conduits in coronary artery bypass grafting. Semin Thorac Cardiovasc Surg. 2013; 25(4):273-9.
    View in: PubMed
  88. Thukkani AK, Fonarow GC, Cannon CP, Cox M, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Schwamm LH, Bhatt DL. Quality of Care for Patients With Acute Coronary Syndromes as a Function of Hospital Revascularization Capability: Insights From Get With The Guidelines-CAD. Clin Cardiol. 2014 May; 37(5):285-92.
    View in: PubMed
  89. Howard JP, Cole GD, Sievert H, Bhatt DL, Papademetriou V, Kandzari DE, Davies JE, Francis DP. Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions. Int J Cardiol. 2014 Mar 1; 172(1):29-35.
    View in: PubMed
  90. Bonaca MP, Bhatt DL, Braunwald E, Cohen M, Steg PG, Storey RF, Held P, Jensen EC, Sabatine MS. Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. Am Heart J. 2014 Apr; 167(4):437-444.e5.
    View in: PubMed
  91. Shah B, Bangalore S, Gianos E, Liang L, Peacock WF, Fonarow GC, Laskey WK, Hernandez AF, Bhatt DL. Temporal trends in clinical characteristics of patients without known cardiovascular disease with a first episode of myocardial infarction. Am Heart J. 2014 Apr; 167(4):480-488.e1.
    View in: PubMed
  92. Harskamp RE, Wang TY, Bhatt DL, Wiviott SD, Amsterdam EA, Li S, Thomas L, de Winter RJ, Roe MT. Hospital patterns of medical management strategy use for patients with non-ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease. Am Heart J. 2014 Mar; 167(3):355-362.e3.
    View in: PubMed
  93. Feres F, Costa RA, Abizaid A, Leon MB, Marin-Neto JA, Botelho RV, King SB, Negoita M, Liu M, de Paula JE, Mangione JA, Meireles GX, Castello HJ, Nicolela EL, Perin MA, Devito FS, Labrunie A, Salvadori D, Gusmão M, Staico R, Costa JR, de Castro JP, Abizaid AS, Bhatt DL. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA. 2013 Dec 18; 310(23):2510-22.
    View in: PubMed
  94. Ademi Z, Huq MM, Liew D, Steg PG, Bhatt DL, Nelson M, Reid CM. The Impact of Lost Therapeutic Benefit (LTB) in High-Risk Hypertensive Patients: 2-Year Follow-Up Data from the Australian REACH Registry. Cardiovasc Ther. 2013 Dec; 31(6):370-6.
    View in: PubMed
  95. Ruff CT, Bhatt DL, Steg PG, Gersh BJ, Alberts MJ, Hoffman EB, Ohman EM, Eagle KA, Lip GY, Goto S. Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry. Int J Cardiol. 2014 Jan 1; 170(3):413-8.
    View in: PubMed
  96. Kohli P, Steg PG, Cannon CP, Smith SC, Eagle KA, Ohman EM, Alberts MJ, Hoffman E, Guo J, Simon T, Sorbets E, Goto S, Bhatt DL. NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease. Am J Med. 2014 Jan; 127(1):53-60.e1.
    View in: PubMed
  97. Cumbler E, Wald H, Bhatt DL, Cox M, Xian Y, Reeves M, Smith EE, Schwamm L, Fonarow GC. Quality of care and outcomes for in-hospital ischemic stroke: findings from the national get with the guidelines-stroke. Stroke. 2014 Jan; 45(1):231-8.
    View in: PubMed
  98. Ferreiro JL, Bhatt DL, Ueno M, Bauer D, Angiolillo DJ. Impact of Smoking on Long-Term Outcomes in Patients With Atherosclerotic Vascular Disease Treated With Aspirin or Clopidogrel: Insights From the CAPRIE Trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events). J Am Coll Cardiol. 2014 Mar 4; 63(8):769-77.
    View in: PubMed
  99. Thukkani AK, Bhatt DL. Renal denervation therapy for hypertension. Circulation. 2013 Nov 12; 128(20):2251-4.
    View in: PubMed
  100. Matteau A, Bhatt DL. Recent advances in antithrombotic therapy after acute coronary syndrome. CMAJ. 2014 May 13; 186(8):589-96.
    View in: PubMed
  101. Bhatt DL. Ask the doctor. I had a heart attack 20 years ago. My doctor told me to stop taking vitamin E. My old cardiologist told me to take vitamin E every day to prevent another heart attack. What should I do? Harv Heart Lett. 2013 Nov; 24(3):2.
    View in: PubMed
  102. Bhatt DL. The latest research advances in invasive cardiology. J Invasive Cardiol. 2013 Nov; 25(11):1p following E207-9.
    View in: PubMed
  103. Bhatt DL. Ask the doctor. I've been smoking for over 40 years. I've tried and tried but just can't quit. Would it help just to cut back instead of stopping? Harv Heart Lett. 2013 Nov; 24(3):2.
    View in: PubMed
  104. Anderson ML, Peterson ED, Peng SA, Wang TY, Ohman EM, Bhatt DL, Saucedo JF, Roe MT. Differences in the Profile, Treatment, and Prognosis of Patients With Cardiogenic Shock by Myocardial Infarction Classification: A Report From NCDR. Circ Cardiovasc Qual Outcomes. 2013 Nov 1; 6(6):708-15.
    View in: PubMed
  105. Maddox TM, Chan PS, Spertus JA, Tang F, Jones P, Ho PM, Bradley SM, Tsai TT, Bhatt DL, Peterson PN. Variations in Coronary Artery Disease Secondary Prevention Prescriptions Among Outpatient Cardiology Practices: Insights From the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2014 Feb 18; 63(6):539-46.
    View in: PubMed
  106. Généreux P, Stone GW, Harrington RA, Gibson CM, Steg PG, Brener SJ, Angiolillo DJ, Price MJ, Prats J, Lasalle L, Liu T, Todd M, Skerjanec S, Hamm CW, Mahaffey KW, White HD, Bhatt DL. Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention). J Am Coll Cardiol. 2014 Feb 25; 63(7):619-29.
    View in: PubMed
  107. Malin SK, Samat A, Wolski K, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy. Int J Obes (Lond). 2014 Mar; 38(3):364-70.
    View in: PubMed
  108. Ellrodt AG, Fonarow GC, Schwamm LH, Albert N, Bhatt DL, Cannon CP, Hernandez AF, Hlatky MA, Luepker RV, Peterson PN, Reeves M, Smith EE. Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes. Circulation. 2013 Nov 26; 128(22):2447-60.
    View in: PubMed
  109. Rodriguez F, Cannon CP, Steg PG, Kumbhani DJ, Goto S, Smith SC, Eagle KA, Ohman EM, Umez-Eronini AA, Hoffman E, Bhatt DL. Predictors of Long-term Adherence to Evidence-based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry. Clin Cardiol. 2013 Dec; 36(12):721-7.
    View in: PubMed
  110. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013 Oct 23; 310(16):1711-20.
    View in: PubMed
  111. Hsich EM, Grau-Sepulveda MV, Hernandez AF, Eapen ZJ, Xian Y, Schwamm LH, Bhatt DL, Fonarow GC. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: Findings from the Get With The Guideline-Heart Failure Registry. Am Heart J. 2013 Dec; 166(6):1063-1071.e3.
    View in: PubMed
  112. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013; 347:f5934.
    View in: PubMed
  113. Mahfoud F, Bhatt DL. Catheter-based renal denervation: the black box procedure. JACC Cardiovasc Interv. 2013 Oct; 6(10):1092-4.
    View in: PubMed
  114. Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013 Dec 17; 62(24):2261-73.
    View in: PubMed
  115. Cavender MA, Rassi AN, Fonarow GC, Cannon CP, Peacock WF, Laskey WK, Hernandez AF, Peterson ED, Cox M, Grau-Sepulveda M, Schwamm LH, Bhatt DL. Relationship of Race/Ethnicity With Door-to-Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Findings From Get With the Guidelines-Coronary Artery Disease. Clin Cardiol. 2013 Dec; 36(12):749-56.
    View in: PubMed
  116. Chan PS, Rao SV, Bhatt DL, Rumsfeld JS, Gurm HS, Nallamothu BK, Cavender MA, Kennedy KF, Spertus JA. Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions. J Am Coll Cardiol. 2013 Dec 17; 62(24):2274-81.
    View in: PubMed
  117. Lee D, Goodman SG, Fox KA, DeYoung JP, Lai CC, Bhatt DL, Huynh T, Yan RT, Gallo R, Steg PG, Yan AT. Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension. Am Heart J. 2013 Oct; 166(4):716-22.
    View in: PubMed
  118. Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, White HD, Harrington RA. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet. 2013 Dec 14; 382(9909):1981-92.
    View in: PubMed
  119. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013 Oct 3; 369(14):1317-26.
    View in: PubMed
  120. Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines-stroke hospitals. Circ Cardiovasc Qual Outcomes. 2013 Sep 1; 6(5):543-9.
    View in: PubMed
  121. Bhatt DL. Insights and lessons useful to everyday practice. J Invasive Cardiol. 2013 Sep; 25(9):A5.
    View in: PubMed
  122. Steinberg BA, Beckley PD, Deering TF, Clark CL, Amin AN, Bauer KA, Cryer B, Mansour M, Scheiman JM, Zenati MA, Newby LK, Peacock WF, Bhatt DL. Evaluation and management of the atrial fibrillation patient: a report from the Society of Cardiovascular Patient Care. Crit Pathw Cardiol. 2013 Sep; 12(3):107-15.
    View in: PubMed
  123. Steen DL, Bhatt DL. Statin potency associated with incident diabetes in a real-world evaluation. Evid Based Med. 2014 Apr; 19(2):68.
    View in: PubMed
  124. Svendsen MC, Akingba AG, Sinha AK, Chattin B, Turner A, Brass M, Bhatt DL, Kassab GS. Conductance sizing balloon for measurement of peripheral artery minimal stent area. J Vasc Surg. 2014 Sep; 60(3):759-66.
    View in: PubMed
  125. Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Fonarow GC. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug; 2(4):e000214.
    View in: PubMed
  126. Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet. 2013 Aug 17; 382(9892):605-13.
    View in: PubMed
  127. Curzen N, Gurbel PA, Myat A, Bhatt DL, Redwood SR. What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention? Lancet. 2013 Aug 17; 382(9892):633-43.
    View in: PubMed
  128. Gutierrez A, Tsai TT, Stanislawski MA, Vidovich M, Bryson CL, Bhatt DL, Grunwald GK, Rumsfeld J, Rao SV. Adoption of transradial percutaneous coronary intervention and outcomes according to center radial volume in the Veterans Affairs Healthcare system: insights from the Veterans Affairs clinical assessment, reporting, and tracking (CART) program. Circ Cardiovasc Interv. 2013 Aug; 6(4):336-46.
    View in: PubMed
  129. Krim SR, Vivo RP, Krim NR, Qian F, Cox M, Ventura H, Hernandez AF, Bhatt DL, Fonarow GC. Racial/Ethnic differences in B-type natriuretic Peptide levels and their association with care and outcomes among patients hospitalized with heart failure: findings from get with the guidelines-heart failure. JACC Heart Fail. 2013 Aug; 1(4):345-52.
    View in: PubMed
  130. Udell JA, Steg PG, Scirica BM, Eagle KA, Ohman EM, Goto S, Alsheikh-Ali AA, Porath A, Corbalan R, Umez-Eronini AA, Hoffman EB, Wilson PW, Bhatt DL. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis. Eur J Prev Cardiol. 2014 Dec; 21(12):1531-40.
    View in: PubMed
  131. Bhatt DL, Harrington RA. Platelet inhibition with cangrelor during PCI. N Engl J Med. 2013 Jul 25; 369(4):393-4.
    View in: PubMed
  132. Maron BA, Choudhary G, Khan UA, Jankowich MD, McChesney H, Ferrazzani SJ, Gaddam S, Sharma S, Opotowsky AR, Bhatt DL, Rocco TP, Aragam JR. Clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients. Circ Heart Fail. 2013 Sep 1; 6(5):906-12.
    View in: PubMed
  133. Bangalore S, Bhatt DL. Coronary intravascular ultrasound. Circulation. 2013 Jun 25; 127(25):e868-74.
    View in: PubMed
  134. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Hoffman E, Goto S, Ohman EM, Bhatt DL. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. Am J Med. 2013 Aug; 126(8):693-700.e1.
    View in: PubMed
  135. Ali SF, Smith EE, Bhatt DL, Fonarow GC, Schwamm LH. Paradoxical association of smoking with in-hospital mortality among patients admitted with acute ischemic stroke. J Am Heart Assoc. 2013 Jun; 2(3):e000171.
    View in: PubMed
  136. Chan PS, Berg RA, Spertus JA, Schwamm LH, Bhatt DL, Fonarow GC, Heidenreich PA, Nallamothu BK, Tang F, Merchant RM. Risk-standardizing survival for in-hospital cardiac arrest to facilitate hospital comparisons. J Am Coll Cardiol. 2013 Aug 13; 62(7):601-9.
    View in: PubMed
  137. Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Todd M, Bhatt DL, Stone GW, Lincoff AM, Dauerman HL, Gibson CM, White HD, Parikh KH, Gruberg L, Herrmann HC, McLaurin BT, Goodman SG, Mahaffey KW. Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial. Coron Artery Dis. 2013 Jun; 24(4):321-7.
    View in: PubMed
  138. Chen HY, Koo BK, Bhatt DL, Kassab GS. Impact of stent mis-sizing and mis-positioning on coronary fluid wall shear and intramural stress. J Appl Physiol (1985). 2013 Jul 15; 115(2):285-92.
    View in: PubMed
  139. Mosenzon O, Raz I, Scirica BM, Hirshberg B, Stahre CI, Steg PG, Davidson J, Ohman P, Price DL, Frederich B, Udell JA, Braunwald E, Bhatt DL. Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial. Diabetes Metab Res Rev. 2013 Jul; 29(5):417-26.
    View in: PubMed
  140. Kumbhani DJ, Bavry AA, Desai MY, Bangalore S, Bhatt DL. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol. 2013 Oct 15; 62(16):1409-18.
    View in: PubMed
  141. Subherwal S, Patel MR, Tang F, Smolderen KG, Jones WS, Tsai TT, Ting HH, Bhatt DL, Spertus JA, Chan PS. Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE Registry. J Am Coll Cardiol. 2013 Jul 2; 62(1):51-7.
    View in: PubMed
  142. Qian F, Fonarow GC, Smith EE, Xian Y, Pan W, Hannan EL, Shaw BA, Glance LG, Peterson ED, Eapen ZJ, Hernandez AF, Schwamm LH, Bhatt DL. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke. Circ Cardiovasc Qual Outcomes. 2013 May 1; 6(3):284-92.
    View in: PubMed
  143. Huo Y, Wischgoll T, Choy JS, Sola S, Navia JL, Teague SD, Bhatt DL, Kassab GS. CT-based diagnosis of diffuse coronary artery disease on the basis of scaling power laws. Radiology. 2013 Sep; 268(3):694-701.
    View in: PubMed
  144. Kassab GS, Bhatt DL, Lefèvre T, Louvard Y. Relation of angiographic side branch calibre to myocardial mass: a proof of concept myocardial infarct index. EuroIntervention. 2013 Apr 22; 8(12):1461-3.
    View in: PubMed
  145. Mohareb M, Goodman SG, Yan RT, Bhatt DL, Elbarouni B, Deyoung JP, Gallo R, Kornder JM, Welsh RC, Saposnik G, Rose B, Wong GC, Grondin FR, Yan AT. Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease. Int J Cardiol. 2013 Oct 3; 168(3):2720-5.
    View in: PubMed
  146. Gibson CM, Chakrabarti AK, Mega J, Bode C, Bassand JP, Verheugt FW, Bhatt DL, Goto S, Cohen M, Mohanavelu S, Burton P, Stone G, Braunwald E. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. J Am Coll Cardiol. 2013 Jul 23; 62(4):286-90.
    View in: PubMed
  147. Myat A, Redwood SR, Qureshi AC, Thackray S, Cleland JG, Bhatt DL, Williams B, Gersh BJ. Renal sympathetic denervation therapy for resistant hypertension: a contemporary synopsis and future implications. Circ Cardiovasc Interv. 2013 Apr; 6(2):184-97.
    View in: PubMed
  148. James ML, Grau-Sepulveda MV, Olson DM, Smith EE, Hernandez AF, Peterson ED, Schwamm LH, Bhatt DL, Fonarow GC. Insurance status and outcome after intracerebral hemorrhage: findings from get with the guidelines-stroke. J Stroke Cerebrovasc Dis. 2014 Feb; 23(2):283-92.
    View in: PubMed
  149. Ademi Z, Liew D, Zomer E, Gorelik A, Hollingsworth B, Steg PG, Bhatt DL, Reid CM. Outcomes and excess costs among patients with cardiovascular disease. Heart Lung Circ. 2013 Sep; 22(9):724-30.
    View in: PubMed
  150. Messé SR, Pervez MA, Smith EE, Siddique KA, Hellkamp AS, Saver JL, Bhatt DL, Fonarow GC, Peterson ED, Schwamm LH. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. Stroke. 2013 May; 44(5):1354-9.
    View in: PubMed
  151. Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, Price MJ, Leonardi S, Gallup D, Bramucci E, Radke PW, Widimský P, Tousek F, Tauth J, Spriggs D, McLaurin BT, Angiolillo DJ, Généreux P, Liu T, Prats J, Todd M, Skerjanec S, White HD, Harrington RA. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med. 2013 Apr 4; 368(14):1303-13.
    View in: PubMed
  152. Bhatt DL. Timely PCI for STEMI--still the treatment of choice. N Engl J Med. 2013 Apr 11; 368(15):1446-7.
    View in: PubMed
  153. Clarke JC, Aragam JR, Bhatt DL, Brown JD, Ferrazzani S, Pietro DA, Maron BA. An unusual cause of dyspnea diagnosed late in life: severe pulmonary hypertension resulting from isolated anomalous pulmonary venous connection. Circ Cardiovasc Imaging. 2013 Mar 1; 6(2):349-51.
    View in: PubMed
  154. Udell JA, Steg PG, Bhatt DL. Impact of loneliness and living alone--reply. JAMA Intern Med. 2013 Feb 25; 173(4):322-3.
    View in: PubMed
  155. Hess PL, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Bhatt DL, Schwamm LH, Yancy CW, Fonarow GC, Al-Khatib SM. Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure. J Cardiovasc Electrophysiol. 2013 Jun; 24(6):664-71.
    View in: PubMed
  156. Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul-Ghani M, Abood B, Pothier CE, Brethauer S, Nissen S, Gupta M, Kirwan JP, Schauer PR. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013 Aug; 36(8):2175-82.
    View in: PubMed
  157. Leonardi S, Truffa AA, Neely ML, Tricoci P, White HD, Gibson CM, Wilson M, Stone GW, Harrington RA, Bhatt DL, Mahaffey KW. A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial. Heart. 2013 Sep; 99(17):1282-7.
    View in: PubMed
  158. Bui AL, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Yancy CW, Bhatt DL, Fonarow GC. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. Am Heart J. 2013 Apr; 165(4):567-574.e6.
    View in: PubMed
  159. Bangalore S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Slater J, Kumar S, Bhatt DL. Response to letter regarding article, “Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison Analysis of 117,762 patient-years of follow-up from randomized trials”. Circulation. 2013 Feb 12; 127(6):e447.
    View in: PubMed
  160. Bangalore S, Steg PG, Bhatt DL. ß-Blocker use for patients with or at risk for coronary artery disease--reply. JAMA. 2013 Feb 6; 309(5):439-40.
    View in: PubMed
  161. Bhatt DL. Pushing the boundaries of renal denervation for resistant hypertension. Catheter Cardiovasc Interv. 2013 Feb; 81(2):340-1.
    View in: PubMed
  162. Huo Y, Choy JS, Wischgoll T, Luo T, Teague SD, Bhatt DL, Kassab GS. Computed tomography-based diagnosis of diffuse compensatory enlargement of coronary arteries using scaling power laws. J R Soc Interface. 2013 Apr 6; 10(81):20121015.
    View in: PubMed
  163. Seif F, Patel SR, Walia H, Rueschman M, Bhatt DL, Gottlieb DJ, Lewis EF, Patil SP, Punjabi NM, Babineau DC, Redline S, Mehra R. Association between obstructive sleep apnea severity and endothelial dysfunction in an increased background of cardiovascular burden. J Sleep Res. 2013 Aug; 22(4):443-51.
    View in: PubMed
  164. Frelinger AL, Bhatt DL, Lee RD, Mulford DJ, Wu J, Nudurupati S, Nigam A, Lampa M, Brooks JK, Barnard MR, Michelson AD. Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function. J Am Coll Cardiol. 2013 Feb 26; 61(8):872-9.
    View in: PubMed
  165. Agrawal K, Bhatt DL. Antiplatelet therapy: Does prasugrel or ticagrelor suffice in patients with STEMI? Nat Rev Cardiol. 2013 Mar; 10(3):121-2.
    View in: PubMed
  166. Sirimarco G, Amarenco P, Labreuche J, Touboul PJ, Alberts M, Goto S, Rother J, Mas JL, Bhatt DL, Steg PG. Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis. Stroke. 2013 Feb; 44(2):373-9.
    View in: PubMed
  167. Masrur S, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Zhao X, Olson D, Pan W, Hernandez AF, Fonarow GC, Schwamm LH. Dysphagia Screening and Hospital-acquired Pneumonia in Patients with Acute Ischemic Stroke: Findings from Get with the Guidelines-Stroke. J Stroke Cerebrovasc Dis. 2013 Nov; 22(8):e301-9.
    View in: PubMed
  168. Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN, Johnson T, Castillo BA, Barnard J, Baumert J, Chang YP, Elbers CC, Farrall M, Fischer ME, Franceschini N, Gaunt TR, Gho JM, Gieger C, Gong Y, Isaacs A, Kleber ME, Mateo Leach I, McDonough CW, Meijs MF, Mellander O, Molony CM, Nolte IM, Padmanabhan S, Price TS, Rajagopalan R, Shaffer J, Shah S, Shen H, Soranzo N, van der Most PJ, Van Iperen EP, Van Setten J, Van Setten JA, Vonk JM, Zhang L, Beitelshees AL, Berenson GS, Bhatt DL, Boer JM, Boerwinkle E, Burkley B, Burt A, Chakravarti A, Chen W, Cooper-Dehoff RM, Curtis SP, Dreisbach A, Duggan D, Ehret GB, Fabsitz RR, Fornage M, Fox E, Furlong CE, Gansevoort RT, Hofker MH, Hovingh GK, Kirkland SA, Kottke-Marchant K, Kutlar A, Lacroix AZ, Langaee TY, Li YR, Lin H, Liu K, Maiwald S, Malik R, Murugesan G, Newton-Cheh C, O'Connell JR, Onland-Moret NC, Ouwehand WH, Palmas W, Penninx BW, Pepine CJ, Pettinger M, Polak JF, Ramachandran VS, Ranchalis J, Redline S, Ridker PM, Rose LM, Scharnag H, Schork NJ, Shimbo D, Shuldiner AR, Srinivasan SR, Stolk RP, Taylor HA, Thorand B, Trip MD, van Duijn CM, Verschuren WM, Wijmenga C, Winkelmann BR, Wyatt S, Young JH, Boehm BO, Caulfield MJ, Chasman DI, Davidson KW, Doevendans PA, Fitzgerald GA, Gums JG, Hakonarson H, Hillege HL, Illig T, Jarvik GP, Johnson JA, Kastelein JJ, Koenig W, März W, Mitchell BD, Murray SS, Oldehinkel AJ, Rader DJ, Reilly MP, Reiner AP, Schadt EE, Silverstein RL, Snieder H, Stanton AV, Uitterlinden AG, van der Harst P, van der Schouw YT, Samani NJ, Johnson AD, Munroe PB, de Bakker PI, Zhu X, Levy D, Keating BJ, Asselbergs FW. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet. 2013 Apr 15; 22(8):1663-78.
    View in: PubMed
  169. Ducrocq G, Amarenco P, Labreuche J, Alberts MJ, Mas JL, Ohman EM, Goto S, Lavallée P, Bhatt DL, Steg PG. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease. Circulation. 2013 Feb 12; 127(6):730-8.
    View in: PubMed
  170. Bhatt DL, Cavender MA. Are all clinical trial sites created equal? J Am Coll Cardiol. 2013 Feb 5; 61(5):580-1.
    View in: PubMed
  171. Tam LM, Fonarow GC, Bhatt DL, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Schwamm LH, Giugliano RP. Achievement of guideline-concordant care and in-hospital outcomes in patients with coronary artery disease in teaching and nonteaching hospitals: results from the Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2013 Jan 1; 6(1):58-65.
    View in: PubMed
  172. Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, Albert NM, Antman EM, Arnett DK, Bertolet M, Bhatt DL, Brindis RG, Creager MA, DeMets DL, Dickersin K, Fonarow GC, Gibbons RJ, Halperin JL, Hochman JS, Koster MA, Normand SL, Ortiz E, Peterson ED, Roach WH, Sacco RL, Smith SC, Stevenson WG, Tomaselli GF, Yancy CW, Zoghbi WA. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 15; 127(2):268-310.
    View in: PubMed
  173. Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, Albert NM, Antman EM, Arnett DK, Bertolet M, Bhatt DL, Brindis RG, Creager MA, DeMets DL, Dickersin K, Fonarow GC, Gibbons RJ, Halperin JL, Hochman JS, Koster MA, Normand SL, Ortiz E, Peterson ED, Roach WH, Sacco RL, Smith SC, Stevenson WG, Tomaselli GF, Yancy CW, Zoghbi WA, Harold JG, He Y, Mangu PB, Qaseem A, Sayre MR, Somerfield MR. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jan 15; 61(2):213-65.
    View in: PubMed
  174. Huang PH, Croce KJ, Bhatt DL, Resnic FS. Recommendations for management of antiplatelet therapy in patients undergoing elective noncardiac surgery after coronary stent implantation. Crit Pathw Cardiol. 2012 Dec; 11(4):177-85.
    View in: PubMed
  175. Feres F, Costa RA, Bhatt DL, Leon MB, Botelho RV, King SB, de Paula JE, Mangione JA, Salvadori D, Gusmão MO, Castello H, Nicolela E, Perin MA, Devito FS, Marin-Neto JA, Abizaid A. Optimized Duration of clopidogrel therapy following treatment with the endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter study. Am Heart J. 2012 Dec; 164(6):810-6.e3.
    View in: PubMed
  176. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Crowley K, Goto S, Ohman EM, Bakris GL, Perlstein TS, Kinlay S, Bhatt DL. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J. 2013 Apr; 34(16):1204-14.
    View in: PubMed
  177. Rassi AN, Cavender MA, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Rosas SE, Zhao X, Schwamm LH, Bhatt DL. Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. J Am Coll Cardiol. 2013 Jan 8; 61(1):35-40.
    View in: PubMed
  178. Depta JP, Bhatt DL. Antiplatelet therapy and proton pump inhibition: cause for concern? Curr Opin Cardiol. 2012 Nov; 27(6):642-50.
    View in: PubMed
  179. Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL. ß-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012 Oct 3; 308(13):1340-9.
    View in: PubMed
  180. Capodanno D, Bhatt DL, Goto S, O'Donoghue ML, Moliterno DJ, Tamburino C, Angiolillo DJ. Safety and efficacy of protease-activated receptor-1 antagonists in patients with coronary artery disease: a meta-analysis of randomized clinical trials. J Thromb Haemost. 2012 Oct; 10(10):2006-15.
    View in: PubMed
  181. Ghosh D, Kuchroo P, Viswanathan C, Sachan S, Shah B, Bhatt D, Parasramani S, Savant S. Efficacy and safety of autologous cultured melanocytes delivered on poly (DL-lactic acid) film: a prospective, open-label, randomized, multicenter study. Dermatol Surg. 2012 Dec; 38(12):1981-90.
    View in: PubMed
  182. Fuster V, Bhatt DL, Califf RM, Michelson AD, Sabatine MS, Angiolillo DJ, Bates ER, Cohen DJ, Coller BS, Furie B, Hulot JS, Mann KG, Mega JL, Musunuru K, O'Donnell CJ, Price MJ, Schneider DJ, Simon DI, Weitz JI, Williams MS, Hoots WK, Rosenberg YD, Hasan AA. Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. Circulation. 2012 Sep 25; 126(13):1645-62.
    View in: PubMed
  183. Bhatt DL. Antiplatelet therapy following myocardial infarction in patients with diabetes. JAMA. 2012 Sep 5; 308(9):921-2.
    View in: PubMed
  184. Bhatt DL. EXAMINATION of new drug-eluting stents--top of the class! Lancet. 2012 Oct 27; 380(9852):1453-5.
    View in: PubMed
  185. Kar S, Bhatt DL. Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents. Coron Artery Dis. 2012 Sep; 23(6):380-90.
    View in: PubMed
  186. Somma KA, Bhatt DL, Fonarow GC, Cannon CP, Cox M, Laskey W, Peacock WF, Hernandez AF, Peterson ED, Schwamm L, Saxon LA. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012 Sep 1; 5(5):654-61.
    View in: PubMed
  187. Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD, Harrington RA, Bhatt DL, Ferrari VA, Fisher JD, Garcia MJ, Gardner TJ, Gentile F, Gilson MF, Hernandez AF, Jacobs AK, Kaul S, Linderbaum JA, Moliterno DJ, Weitz HH. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg. 2012 Sep; 144(3):e29-84.
    View in: PubMed
  188. Banerjee S, Xu H, Fuh E, Nguyen KT, Garcia JA, Brilakis ES, Bhatt DL. Endothelial progenitor cell response to antiproliferative drug exposure. Atherosclerosis. 2012 Nov; 225(1):91-8.
    View in: PubMed
  189. Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteza M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012 Oct 4; 367(14):1297-309.
    View in: PubMed
  190. Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Pan W, Schwamm LH, Bhatt DL. Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med. 2013 Jan; 126(1):74.e1-9.
    View in: PubMed
  191. Boyer NM, Laskey WK, Cox M, Hernandez AF, Peterson ED, Bhatt DL, Cannon CP, Fonarow GC. Trends in clinical, demographic, and biochemical characteristics of patients with acute myocardial infarction from 2003 to 2008: a report from the american heart association get with the guidelines coronary artery disease program. J Am Heart Assoc. 2012 Aug; 1(4):e001206.
    View in: PubMed
  192. Focks JJ, Brouwer MA, van Oijen MG, Lanas A, Bhatt DL, Verheugt FW. Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome- a systematic review. Heart. 2013 Apr; 99(8):520-7.
    View in: PubMed
  193. Udell JA, Steg PG, Scirica BM, Smith SC, Ohman EM, Eagle KA, Goto S, Cho JI, Bhatt DL. Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis. Arch Intern Med. 2012 Jul 23; 172(14):1086-95.
    View in: PubMed
  194. Theodos G, Raymond C, Becker MC, Thornton J, Ellis SG, Bhatt DL, Raymond RE. Arteriotomy closure device safety after percutaneous coronary intervention in the direct thrombin inhibitor era: a comparative study. Catheter Cardiovasc Interv. 2013 Feb; 81(2):294-300.
    View in: PubMed
  195. Murthy VL, Desai NR, Vora A, Bhatt DL. Increasing proportion of clinical trials using noninferiority end points. Clin Cardiol. 2012 Sep; 35(9):522-3.
    View in: PubMed
  196. Udell JA, Scirica BM, Braunwald E, Raz I, Steg PG, Davidson J, Hirshberg B, Bhatt DL. Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus. Clin Cardiol. 2012 Dec; 35(12):722-9.
    View in: PubMed
  197. Bhatt DL, Bakris GL. The promise of renal denervation. Cleve Clin J Med. 2012 Jul; 79(7):498-500.
    View in: PubMed
  198. O'Donoghue ML, Bhatt DL, Flather MD, Goto S, Angiolillo DJ, Goodman SG, Zeymer U, Aylward PE, Montalescot G, Ziecina R, Kobayashi H, Ren F, Wiviott SD. Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program. J Thromb Thrombolysis. 2012 Jul; 34(1):36-43.
    View in: PubMed
  199. Wilson PW, D'Agostino R, Bhatt DL, Eagle K, Pencina MJ, Smith SC, Alberts MJ, Dallongeville J, Goto S, Hirsch AT, Liau CS, Ohman EM, Röther J, Reid C, Mas JL, Steg PG. An international model to predict recurrent cardiovascular disease. Am J Med. 2012 Jul; 125(7):695-703.e1.
    View in: PubMed
  200. Angiolillo DJ, Schneider DJ, Bhatt DL, French WJ, Price MJ, Saucedo JF, Shaburishvili T, Huber K, Prats J, Liu T, Harrington RA, Becker RC. Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials. J Thromb Thrombolysis. 2012 Jul; 34(1):44-55.
    View in: PubMed
  201. Vasaiwala S, Cannon CP, Fonarow GC, Peacock WF, Laskey W, Schwamm LH, Liang L, Hernandez AF, Peterson ED, Rosas SE, Bhatt DL. Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program. Clin Cardiol. 2012 Sep; 35(9):541-7.
    View in: PubMed
  202. Medina HM, Cannon CP, Fonarow GC, Grau-Sepulveda MV, Hernandez AF, Frank Peacock W, Laskey W, Peterson ED, Schwamm L, Bhatt DL. Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease. Clin Cardiol. 2012 Oct; 35(10):632-40.
    View in: PubMed
  203. Bangalore S, Fonarow GC, Peterson ED, Hellkamp AS, Hernandez AF, Laskey W, Peacock WF, Cannon CP, Schwamm LH, Bhatt DL. Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med. 2012 Oct; 125(10):1000-9.
    View in: PubMed
  204. Bansilal S, Bhatt DL. Clopidogrel resistance - a clear problem with an unclear solution. Indian Heart J. 2012 Jul-Aug; 64(4):353-5.
    View in: PubMed
  205. Subherwal S, Bhatt DL, Li S, Wang TY, Thomas L, Alexander KP, Patel MR, Ohman EM, Gibler WB, Peterson ED, Roe MT. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012 Jul 1; 5(4):541-9.
    View in: PubMed
  206. Depta JP, Fowler J, Novak E, Katzan I, Bakdash S, Kottke-Marchant K, Bhatt DL. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack. Stroke. 2012 Sep; 43(9):2376-81.
    View in: PubMed
  207. Duval S, Massaro JM, Jaff MR, Boden WE, Alberts MJ, Califf RM, Eagle KA, D'Agostino RB, Pedley A, Fonarow GC, Murabito JM, Steg PG, Bhatt DL, Hirsch AT. An evidence-based score to detect prevalent peripheral artery disease (PAD). Vasc Med. 2012 Oct; 17(5):342-51.
    View in: PubMed
  208. Cantú-Brito C, Chiquete E, Ruiz-Sandoval JL, Gaxiola E, Albuquerque DC, Corbalán R, Ramos A, Bhatt DL, Steg PG. Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH Registry. Clin Cardiol. 2012 Aug; 35(8):451-7.
    View in: PubMed
  209. Welsh RC, Rao SV, Zeymer U, Thompson VP, Huber K, Kochman J, McClure MW, Gretler DD, Bhatt DL, Gibson CM, Angiolillo DJ, Gurbel PA, Berdan LG, Paynter G, Leonardi S, Madan M, French WJ, Harrington RA. A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial. Circ Cardiovasc Interv. 2012 Jun; 5(3):336-46.
    View in: PubMed
  210. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012 Jul 3; 126(1):65-75.
    View in: PubMed
  211. Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012 Jun 12; 125(23):2873-91.
    View in: PubMed
  212. Timur AA, Murugesan G, Zhang L, Aung PP, Barnard J, Wang QK, Gaussem P, Silverstein RL, Bhatt DL, Kottke-Marchant K. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol. 2012 Oct; 34(5):473-83.
    View in: PubMed
  213. Kandzari DE, Bhatt DL, Sobotka PA, O'Neill WW, Esler M, Flack JM, Katzen BT, Leon MB, Massaro JM, Negoita M, Oparil S, Rocha-Singh K, Straley C, Townsend RR, Bakris G. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol. 2012 Sep; 35(9):528-35.
    View in: PubMed
  214. Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: American College of Cardiology Foundation Task Force on expert consensus documents Society of Thoracic Surgeons Society for Vascular Medicine. Catheter Cardiovasc Interv. 2012 Sep 1; 80(3):E37-49.
    View in: PubMed
  215. Roussel R, Hadjadj S, Pasquet B, Wilson PW, Smith SC, Goto S, Tubach F, Marre M, Porath A, Krempf M, Bhatt DL, Steg PG. Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality. Int J Cardiol. 2013 Aug 20; 167(4):1380-4.
    View in: PubMed
  216. Leonardi S, Mahaffey KW, White HD, Gibson CM, Stone GW, Steg GW, Hamm CW, Price MJ, Todd M, Dietrich M, Gallup D, Liu T, Skerjanec S, Harrington RA, Bhatt DL. Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial. Am Heart J. 2012 May; 163(5):768-776.e2.
    View in: PubMed
  217. Bansilal S, Bhatt DL. Declining coronary artery bypass-related mortality: more than meets the eye? Clin Cardiol. 2012 May; 35(5):261-2.
    View in: PubMed
  218. Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD, Harrington RA, Bhatt DL, Ferrari VA, Fisher JD, Garcia MJ, Gardner TJ, Gentile F, Gilson MF, Hernandez AF, Jacobs AK, Kaul S, Linderbaum JA, Moliterno DJ, Weitz HH. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Catheter Cardiovasc Interv. 2012 Jun 1; 79(7):1023-82.
    View in: PubMed
  219. Venkitachalam L, Wang K, Porath A, Corbalan R, Hirsch AT, Cohen DJ, Smith SC, Ohman EM, Steg PG, Bhatt DL, Magnuson EA. Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance. Circulation. 2012 Apr 17; 125(15):1858-69.
    View in: PubMed
  220. Frelinger AL, Lee RD, Mulford DJ, Wu J, Nudurupati S, Nigam A, Brooks JK, Bhatt DL, Michelson AD. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. J Am Coll Cardiol. 2012 Apr 3; 59(14):1304-11.
    View in: PubMed
  221. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 Apr 26; 366(17):1567-76.
    View in: PubMed
  222. Bhatt DL, Paré G, Eikelboom JW, Simonsen KL, Emison ES, Fox KA, Steg PG, Montalescot G, Bhakta N, Hacke W, Flather MD, Mak KH, Cacoub P, Creager MA, Berger PB, Steinhubl SR, Murugesan G, Mehta SR, Kottke-Marchant K, Lincoff AM, Topol EJ. The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. Eur Heart J. 2012 Sep; 33(17):2143-50.
    View in: PubMed
  223. Vivo RP, Krim SR, Krim NR, Zhao X, Hernandez AF, Peterson ED, Piña IL, Bhatt DL, Schwamm LH, Fonarow GC. Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure. Circ Heart Fail. 2012 Mar 1; 5(2):167-75.
    View in: PubMed
  224. Maron BA, Bhatt DL, Nykiel M, Kinlay S, Waxman AB. Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertension. Crit Pathw Cardiol. 2012 Mar; 11(1):40-2.
    View in: PubMed
  225. Hsich EM, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Schwamm LH, Bhatt DL, Fonarow GC. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. Am Heart J. 2012 Mar; 163(3):430-7, 437.e1-3.
    View in: PubMed
  226. Mountantonakis SE, Grau-Sepulveda MV, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC. Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure. Circ Heart Fail. 2012 Mar 1; 5(2):191-201.
    View in: PubMed
  227. Reid CM, Ademi Z, Nelson MR, Connor G, Chew DP, Shiel L, Smeath A, De Looze F, Steg PG, Bhatt DL, Liew D. Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis. Med J Aust. 2012 Feb 20; 196(3):193-7.
    View in: PubMed
  228. Brilakis ES, Banerjee S, Shunk KA, Bhatt DL. Drug-eluting versus bare-metal stents in saphenous vein graft lesions. Lancet. 2012 Feb 18; 379(9816):615; author reply 615-6.
    View in: PubMed
  229. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL, Lanktree MB, Tare A, Castillo BA, Li YR, Johnson T, Bruinenberg M, Gilbert-Diamond D, Rajagopalan R, Voight BF, Balasubramanyam A, Barnard J, Bauer F, Baumert J, Bhangale T, Böhm BO, Braund PS, Burton PR, Chandrupatla HR, Clarke R, Cooper-DeHoff RM, Crook ED, Davey-Smith G, Day IN, de Boer A, de Groot MC, Drenos F, Ferguson J, Fox CS, Furlong CE, Gibson Q, Gieger C, Gilhuijs-Pederson LA, Glessner JT, Goel A, Gong Y, Grant SF, Grobbee DE, Hastie C, Humphries SE, Kim CE, Kivimaki M, Kleber M, Meisinger C, Kumari M, Langaee TY, Lawlor DA, Li M, Lobmeyer MT, Maitland-van der Zee AH, Meijs MF, Molony CM, Morrow DA, Murugesan G, Musani SK, Nelson CP, Newhouse SJ, O'Connell JR, Padmanabhan S, Palmen J, Patel SR, Pepine CJ, Pettinger M, Price TS, Rafelt S, Ranchalis J, Rasheed A, Rosenthal E, Ruczinski I, Shah S, Shen H, Silbernagel G, Smith EN, Spijkerman AW, Stanton A, Steffes MW, Thorand B, Trip M, van der Harst P, van der A DL, van Iperen EP, van Setten J, van Vliet-Ostaptchouk JV, Verweij N, Wolffenbuttel BH, Young T, Zafarmand MH, Zmuda JM, Boehnke M, Altshuler D, McCarthy M, Kao WH, Pankow JS, Cappola TP, Sever P, Poulter N, Caulfield M, Dominiczak A, Shields DC, Bhatt DL, Bhatt D, Zhang L, Curtis SP, Danesh J, Casas JP, van der Schouw YT, Onland-Moret NC, Doevendans PA, Dorn GW, Farrall M, FitzGerald GA, Hamsten A, Hegele R, Hingorani AD, Hofker MH, Huggins GS, Illig T, Jarvik GP, Johnson JA, Klungel OH, Knowler WC, Koenig W, März W, Meigs JB, Melander O, Munroe PB, Mitchell BD, Bielinski SJ, Rader DJ, Reilly MP, Rich SS, Rotter JI, Saleheen D, Samani NJ, Schadt EE, Shuldiner AR, Silverstein R, Kottke-Marchant K, Talmud PJ, Watkins H, Asselbergs FW, Asselbergs F, de Bakker PI, McCaffery J, Wijmenga C, Sabatine MS, Wilson JG, Reiner A, Bowden DW, Hakonarson H, Siscovick DS, Keating BJ. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012 Mar 9; 90(3):410-25.
    View in: PubMed
  230. Subherwal S, Peterson ED, Chen AY, Roe MT, Washam JB, Gage BF, Bach RG, Bhatt DL, Wiviott SD, Lopes RD, Alexander KP, Wang TY. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry. Circulation. 2012 Mar 20; 125(11):1414-23.
    View in: PubMed
  231. White HD, Chew DP, Dauerman HL, Mahaffey KW, Gibson CM, Stone GW, Gruberg L, Harrington RA, Bhatt DL. Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. Am Heart J. 2012 Feb; 163(2):182-90.e4.
    View in: PubMed
  232. Abola MT, Bhatt DL, Duval S, Cacoub PP, Baumgartner I, Keo H, Creager MA, Brennan DM, Steg PG, Hirsch AT. Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes. Atherosclerosis. 2012 Apr; 221(2):527-35.
    View in: PubMed
  233. Moukarbel GV, Bhatt DL. Antiplatelet therapy and proton pump inhibition: clinician update. Circulation. 2012 Jan 17; 125(2):375-80.
    View in: PubMed
  234. Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2012 Jan; 5(1):126-33.
    View in: PubMed
  235. Huang PH, Kim CX, Lerman A, Cannon CP, Dai D, Laskey W, Peacock WF, Hernandez AF, Peterson ED, Smith EE, Fonarow GC, Schwamm LH, Bhatt DL. Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelines. Clin Cardiol. 2012; 35(7):396-403.
    View in: PubMed
  236. Yeo KK, Li S, Amsterdam EA, Wang TY, Bhatt DL, Saucedo JF, Kontos MC, Roe MT, French WJ. Comparison of clinical characteristics, treatments and outcomes of patients with ST-elevation acute myocardial infarction with versus without new or presumed new left bundle branch block (from NCDR®). Am J Cardiol. 2012 Feb 15; 109(4):497-501.
    View in: PubMed
  237. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Jan 5; 366(1):9-19.
    View in: PubMed
  238. Krim SR, Vivo RP, Krim NR, Cox M, Hernandez AF, Peterson ED, Fonarow GC, Piña IL, Schwamm LH, Bhatt DL. Regional differences in clinical profile, quality of care, and outcomes among Hispanic patients hospitalized with acute myocardial infarction in the Get with Guidelines-Coronary Artery Disease (GWTG-CAD) registry. Am Heart J. 2011 Dec; 162(6):988-995.e4.
    View in: PubMed
  239. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Price DL, Chen R, Udell J, Raz I. The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study. Am Heart J. 2011 Nov; 162(5):818-825.e6.
    View in: PubMed
  240. Bangalore S, Bhatt DL. Images in cardiovascular medicine. Right heart catheterization, coronary angiography, and percutaneous coronary intervention. Circulation. 2011 Oct 25; 124(17):e428-33.
    View in: PubMed
  241. Motivala AA, Cannon CP, Srinivas VS, Dai D, Hernandez AF, Peterson ED, Bhatt DL, Fonarow GC. Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? J Am Coll Cardiol. 2011 Oct 18; 58(17):1760-5.
    View in: PubMed
  242. Eapen ZJ, Fonarow GC, Dai D, O'Brien SM, Schwamm LH, Cannon CP, Heidenreich PA, Bhatt DL, Peterson ED, Hernandez AF. Comparison of composite measure methodologies for rewarding quality of care: an analysis from the American Heart Association's Get With The Guidelines program. Circ Cardiovasc Qual Outcomes. 2011 Nov 1; 4(6):610-8.
    View in: PubMed
  243. Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, Donner A, Mamdani M, Douketis JD, Arima H, Chalmers J, MacMahon S, Tirschwell DL, Psaty BM, Bushnell CD, Aguilar MI, Capampangan DJ, Werring DJ, De Rango P, Viswanathan A, Danchin N, Cheng CL, Yang YH, Verdel BM, Lai MS, Kennedy J, Uchiyama S, Yamaguchi T, Ikeda Y, Mrkobrada M. Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation. 2011 Nov 15; 124(20):2233-42.
    View in: PubMed
  244. Smolderen KG, Wang K, de Pouvourville G, Brüggenjürgen B, Röther J, Zeymer U, Parhofer KG, Steg PG, Bhatt DL, Magnuson EA. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease. Eur J Vasc Endovasc Surg. 2012 Feb; 43(2):198-207.
    View in: PubMed
  245. Ademi Z, Reid CM, Hollingsworth B, Stoelwinder J, Steg PG, Bhatt DL, Vale M, Liew D. Cost-effectiveness of optimizing use of statins in Australia: using outpatient data from the REACH Registry. Clin Ther. 2011 Oct; 33(10):1456-65.
    View in: PubMed
  246. Meadows TA, Bhatt DL, Cannon CP, Gersh BJ, Röther J, Goto S, Liau CS, Wilson PW, Salette G, Smith SC, Steg PG. Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Mayo Clin Proc. 2011 Oct; 86(10):960-7.
    View in: PubMed
  247. Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary. Circ Cardiovasc Interv. 2011 Oct 1; 4(5):522-34.
    View in: PubMed
  248. Chen HY, Sinha AK, Choy JS, Zheng H, Sturek M, Bigelow B, Bhatt DL, Kassab GS. Mis-sizing of stent promotes intimal hyperplasia: impact of endothelial shear and intramural stress. Am J Physiol Heart Circ Physiol. 2011 Dec; 301(6):H2254-63.
    View in: PubMed
  249. Lewis WR, Fonarow GC, Grau-Sepulveda MV, Smith EE, Bhatt DL, Hernandez AF, Olson D, Peterson ED, Schwamm LH. Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke. Am Heart J. 2011 Oct; 162(4):692-699.e2.
    View in: PubMed
  250. Keo HH, Baumgartner I, Hirsch AT, Duval S, Steg PG, Pasquet B, Bhatt DL, Roether J. Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease. Vasc Med. 2011 Oct; 16(5):323-30.
    View in: PubMed
  251. Venketasubramanian N, Röther J, Bhatt DL, Pasquet B, Mas JL, Alberts MJ, Hill MD, Aichner F, Steg PG. Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registry. Cerebrovasc Dis. 2011; 32(3):254-60.
    View in: PubMed
  252. Klein L, Grau-Sepulveda MV, Bonow RO, Hernandez AF, Williams MV, Bhatt DL, Fonarow GC. Quality of care and outcomes in women hospitalized for heart failure. Circ Heart Fail. 2011 Sep; 4(5):589-98.
    View in: PubMed
  253. Bangalore S, Bhatt DL. Femoral arterial access and closure. Circulation. 2011 Aug 2; 124(5):e147-56.
    View in: PubMed
  254. Wang TY, Dai D, Hernandez AF, Bhatt DL, Heidenreich PA, Fonarow GC, Peterson ED. The importance of consistent, high-quality acute myocardial infarction and heart failure care results from the American Heart Association's Get with the Guidelines Program. J Am Coll Cardiol. 2011 Aug 2; 58(6):637-44.
    View in: PubMed
  255. Medina HM, Cannon CP, Zhao X, Hernandez AF, Bhatt DL, Peterson ED, Liang L, Fonarow GC. Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD). Am Heart J. 2011 Aug; 162(2):283-290.e2.
    View in: PubMed
  256. Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thromb Haemost. 2011 Oct; 106(4):572-84.
    View in: PubMed
  257. Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L. Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med. 2011 Aug 25; 365(8):699-708.
    View in: PubMed
  258. Yousuf O, Bhatt DL. The evolution of antiplatelet therapy in cardiovascular disease. Nat Rev Cardiol. 2011 Oct; 8(10):547-59.
    View in: PubMed
  259. Berger JS, Bhatt DL, Steg PG, Steinhubl SR, Montalescot G, Shao M, Hacke W, Fox KA, Berger PB, Topol EJ, Lincoff AM. Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J. 2011 Jul; 162(1):98-105.e1.
    View in: PubMed
  260. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Ann Forciea M, Frishman WH, Jaigobin C, Kostis JB, Mancia G, Oparil S, Ortiz E, Reisin E, Rich MW, Schocken DD, Weber MA, Wesley DJ, Harrington RA, Bates ER, Bhatt DL, Bridges CR, Eisenberg MJ, Ferrari VA, Fisher JD, Gardner TJ, Gentile F, Gilson MF, Hlatky MA, Jacobs AK, Kaul S, Moliterno DJ, Mukherjee D, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens. 2011 Jul-Aug; 5(4):259-352.
    View in: PubMed
  261. Ademi Z, Liew D, Hollingsworth B, Steg PG, Bhatt DL, Reid CM. Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort. Cardiovasc Ther. 2013 Feb; 31(1):45-52.
    View in: PubMed
  262. Alberts MJ, Bhatt DL, Smith SC, Röther J, Goto S, Hirsch AT, Steg PG. Risk factors and outcomes for patients with vascular disease and serious bleeding events. Heart. 2011 Sep; 97(18):1507-12.
    View in: PubMed
  263. Simon T, Bhatt DL, Bergougnan L, Farenc C, Pearson K, Perrin L, Vicaut E, Lacreta F, Hurbin F, Dubar M. Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects. Clin Pharmacol Ther. 2011 Aug; 90(2):287-95.
    View in: PubMed
  264. Barthélémy O, Limbourg T, Collet JP, Beygui F, Silvain J, Bellemain-Appaix A, Cayla G, Chastre T, Baumgartner I, Röther J, Zeymer U, Bhatt DL, Steg G, Montalescot G. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors. Int J Cardiol. 2013 Mar 10; 163(3):266-71.
    View in: PubMed
  265. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011 Jun 14; 123(23):2736-47.
    View in: PubMed
  266. Whellan DJ, Zhao X, Hernandez AF, Liang L, Peterson ED, Bhatt DL, Heidenreich PA, Schwamm LH, Fonarow GC. Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines. J Card Fail. 2011 Aug; 17(8):649-56.
    View in: PubMed
  267. Bhatt DL. Evaluation of agents to reduce infarct size: it can be quite REVEALing. JAMA. 2011 May 11; 305(18):1908-9.
    View in: PubMed
  268. O'Donoghue ML, Bhatt DL, Wiviott SD, Goodman SG, Fitzgerald DJ, Angiolillo DJ, Goto S, Montalescot G, Zeymer U, Aylward PE, Guetta V, Dudek D, Ziecina R, Contant CF, Flather MD. Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial. Circulation. 2011 May 3; 123(17):1843-53.
    View in: PubMed
  269. Wiviott SD, Flather MD, O'Donoghue ML, Goto S, Fitzgerald DJ, Cura F, Aylward P, Guetta V, Dudek D, Contant CF, Angiolillo DJ, Bhatt DL. Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial. Circulation. 2011 May 3; 123(17):1854-63.
    View in: PubMed
  270. Morrell J, Zeymer U, Baumgartner I, Limbourg T, Röther J, Bhatt DL, Steg PG. Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe. Eur J Cardiovasc Prev Rehabil. 2011 Apr; 18(2):270-7.
    View in: PubMed
  271. Sakhuja R, Yeh RW, Bhatt DL. Anticoagulant agents in acute coronary syndromes. Curr Probl Cardiol. 2011 Apr; 36(4):127-68.
    View in: PubMed
  272. Allen LA, Hernandez AF, Peterson ED, Curtis LH, Dai D, Masoudi FA, Bhatt DL, Heidenreich PA, Fonarow GC. Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail. 2011 May; 4(3):293-300.
    View in: PubMed
  273. Hermiller J, Choy JS, Svendsen M, Bigelow B, Fouts AM, Hall J, Parr K, Ball M, Sinha A, Bhatt DL, Kassab GS. A nonimaging catheter for measurement of coronary artery lumen area: a first in man pilot study. Catheter Cardiovasc Interv. 2011 Aug 1; 78(2):202-10.
    View in: PubMed
  274. Weber M, Bhatt DL, Brennan DM, Hankey GJ, Steinhubl SR, Johnston SC, Montalescot G, Mak KH, Fox KA, Easton DJ, Topol EJ, Hamm CW. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial. Heart. 2011 Apr; 97(8):626-31.
    View in: PubMed
  275. Bhatt DL. Glycoprotein IIb/IIIa inhibitors: do they still have a role? J Am Coll Cardiol. 2011 Mar 8; 57(10):1200-1.
    View in: PubMed
  276. Kumbhani DJ, Bavry AA, Harvey JE, de Souza R, Scarpioni R, Bhatt DL, Kapadia SR. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J. 2011 Mar; 161(3):622-630.e1.
    View in: PubMed
  277. Chen J, Shi C, Mahoney EM, Dunn ES, Rinfret S, Caro JJ, O'Brien J, El-Hadi W, Bhatt DL, Topol EJ, Cohen DJ. Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial. Can J Cardiol. 2011 Mar-Apr; 27(2):222-31.
    View in: PubMed
  278. Cacoub PP, Zeymer U, Limbourg T, Baumgartner I, Poldermans D, Röther J, Bhatt DL, Steg PG. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart. 2011 Apr; 97(8):660-7.
    View in: PubMed
  279. Dallongeville J, Bhatt DL, Steg PH, Ravaud P, Wilson PW, Eagle KA, Goto S, Mas JL, Montalescot G. Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry. Eur J Prev Cardiol. 2012 Apr; 19(2):241-9.
    View in: PubMed
  280. Gharacholou SM, Hellkamp AS, Hernandez AF, Peterson ED, Bhatt DL, Yancy CW, Fonarow GC. Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program. J Card Fail. 2011 May; 17(5):431-9.
    View in: PubMed
  281. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, Olson DM, Hernandez AF, Peterson ED, Schwamm LH. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011 Feb 22; 123(7):750-8.
    View in: PubMed
  282. Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez A, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). Am Heart J. 2011 Feb; 161(2):418-424.e1-3.
    View in: PubMed
  283. Hankey GJ, Johnston SC, Easton JD, Hacke W, Mas JL, Brennan D, Mak KH, Bhatt DL, Fox KA, Topol EJ. Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Int J Stroke. 2011 Feb; 6(1):3-9.
    View in: PubMed
  284. Kolandaivelu K, Bhatt DL. Antiplatelet therapy in coronary heart disease prevention. Cardiol Clin. 2011 Feb; 29(1):71-85.
    View in: PubMed
  285. Banerjee S, Weideman RA, Weideman MW, Little BB, Kelly KC, Gunter JT, Tortorice KL, Shank M, Cryer B, Reilly RF, Rao SV, Kastrati A, de Lemos JA, Brilakis ES, Bhatt DL. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention. Am J Cardiol. 2011 Mar 15; 107(6):871-8.
    View in: PubMed
  286. Sheikh MA, Bhatt DL, Li J, Lin S, Bartholomew JR. Usefulness of postexercise ankle-brachial index to predict all-cause mortality. Am J Cardiol. 2011 Mar 1; 107(5):778-82.
    View in: PubMed
  287. Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, Onland-Moret NC, Lettre G, Ongen H, Rajagopalan R, Johnson T, Shen H, Nelson CP, Klopp N, Baumert J, Padmanabhan S, Pankratz N, Pankow JS, Shah S, Taylor K, Barnard J, Peters BJ, Maloney CM, Lobmeyer MT, Stanton A, Zafarmand MH, Romaine SP, Mehta A, van Iperen EP, Gong Y, Price TS, Smith EN, Kim CE, Li YR, Asselbergs FW, Atwood LD, Bailey KM, Bhatt D, Bauer F, Behr ER, Bhangale T, Boer JM, Boehm BO, Bradfield JP, Brown M, Braund PS, Burton PR, Carty C, Chandrupatla HR, Chen W, Connell J, Dalgeorgou C, Boer Ad, Drenos F, Elbers CC, Fang JC, Fox CS, Frackelton EC, Fuchs B, Furlong CE, Gibson Q, Gieger C, Goel A, Grobbee DE, Hastie C, Howard PJ, Huang GH, Johnson WC, Li Q, Kleber ME, Klein BE, Klein R, Kooperberg C, Ky B, Lacroix A, Lanken P, Lathrop M, Li M, Marshall V, Melander O, Mentch FD, Meyer NJ, Monda KL, Montpetit A, Murugesan G, Nakayama K, Nondahl D, Onipinla A, Rafelt S, Newhouse SJ, Otieno FG, Patel SR, Putt ME, Rodriguez S, Safa RN, Sawyer DB, Schreiner PJ, Simpson C, Sivapalaratnam S, Srinivasan SR, Suver C, Swergold G, Sweitzer NK, Thomas KA, Thorand B, Timpson NJ, Tischfield S, Tobin M, Tomaszewski M, Tomaszweski M, Verschuren WM, Wallace C, Winkelmann B, Zhang H, Zheng D, Zhang L, Zmuda JM, Clarke R, Balmforth AJ, Danesh J, Day IN, Schork NJ, de Bakker PI, Delles C, Duggan D, Hingorani AD, Hirschhorn JN, Hofker MH, Humphries SE, Kivimaki M, Lawlor DA, Kottke-Marchant K, Mega JL, Mitchell BD, Morrow DA, Palmen J, Redline S, Shields DC, Shuldiner AR, Sleiman PM, Smith GD, Farrall M, Jamshidi Y, Christiani DC, Casas JP, Hall AS, Doevendans PA, Christie JD, Berenson GS, Murray SS, Illig T, Dorn GW, Cappola TP, Boerwinkle E, Sever P, Rader DJ, Reilly MP, Caulfield M, Talmud PJ, Topol E, Engert JC, Wang K, Dominiczak A, Hamsten A, Curtis SP, Silverstein RL, Lange LA, Sabatine MS, Trip M, Saleheen D, Peden JF, Cruickshanks KJ, März W, O'Connell JR, Klungel OH, Wijmenga C, Maitland-van der Zee AH, Schadt EE, Johnson JA, Jarvik GP, Papanicolaou GJ, Grant SF, Munroe PB, North KE, Samani NJ, Koenig W, Gaunt TR, Anand SS, van der Schouw YT, Soranzo N, Fitzgerald GA, Reiner A, Hegele RA, Hakonarson H, Keating BJ. Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet. 2011 Jan 7; 88(1):6-18.
    View in: PubMed
  288. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010 Dec 7; 56(24):2051-66.
    View in: PubMed
  289. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2010 Dec; 105(12):2533-49.
    View in: PubMed
  290. Chiu JF, Bell AD, Herman RJ, Hill MD, Stewart JA, Cohen EA, Liau CS, Steg PG, Bhatt DL. Cardiovascular risk profiles and outcomes of Chinese living inside and outside China. Eur J Cardiovasc Prev Rehabil. 2010 Dec; 17(6):668-75.
    View in: PubMed
  291. Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez AF, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). Am Heart J. 2010 Dec; 160(6):1130-6, 1136.e1-3.
    View in: PubMed
  292. Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC, Goto S, Ravaud P, Marre M, Porath A, Bhatt DL, Steg PG. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med. 2010 Nov 22; 170(21):1892-9.
    View in: PubMed
  293. Cryer B, Bhatt DL, Lanza FL, Dong JF, Lichtenberger LM, Marathi UK. Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial. Am J Gastroenterol. 2011 Feb; 106(2):272-7.
    View in: PubMed
  294. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010 Dec 14; 122(24):2619-33.
    View in: PubMed
  295. Mahoney EM, Wang K, Keo HH, Duval S, Smolderen KG, Cohen DJ, Steg G, Bhatt DL, Hirsch AT. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):642-51.
    View in: PubMed
  296. Bangalore S, Kumar S, Wetterslev J, Bavry AA, Gluud C, Cutlip DE, Bhatt DL. Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol. 2011 Feb; 68(2):172-84.
    View in: PubMed
  297. Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010 Nov 11; 363(20):1909-17.
    View in: PubMed
  298. Aragam KG, Bhatt DL. Antiplatelet therapy in acute coronary syndromes. J Cardiovasc Pharmacol Ther. 2011 Mar; 16(1):24-42.
    View in: PubMed
  299. Smolderen KG, Bell A, Lei Y, Cohen EA, Steg PG, Bhatt DL, Mahoney EM. One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry. Can J Cardiol. 2010 Oct; 26(8):297-305.
    View in: PubMed
  300. Kumbhani DJ, Bhatt DL. Secondary prevention of stroke: can we do better than aspirin? Lancet Neurol. 2010 Oct; 9(10):942-3.
    View in: PubMed
  301. Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, Gachet C, Montalescot G, Jennings LK, Kereiakes D, Sibbing D, Trenk D, Van Werkum JW, Paganelli F, Price MJ, Waksman R, Gurbel PA. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010 Sep 14; 56(12):919-33.
    View in: PubMed
  302. Goyal A, Bhatt DL, Steg PG, Gersh BJ, Alberts MJ, Ohman EM, Corbalán R, Eagle KA, Gaxiola E, Gao R, Goto S, D'Agostino RB, Califf RM, Smith SC, Wilson PW. Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries. Circulation. 2010 Sep 21; 122(12):1167-75.
    View in: PubMed
  303. Boden WE, Cherr GS, Eagle KA, Cannon CP, Califf RM, Hirsch AT, Alberts MJ, Criqui M, Creager MA, Massaro JM, D'Agostino RB, Steg PG, Bhatt DL. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis. Crit Pathw Cardiol. 2010 Sep; 9(3):116-25.
    View in: PubMed
  304. Kar S, Krishnaswamy A, Shishehbor MH, Cam A, Tuzcu EM, Bhatt DL, Bajzer C, Kapadia SR. Safety and efficacy of carotid stenting in individuals with concomitant severe carotid and aortic stenosis. EuroIntervention. 2010 Sep; 6(4):492-7.
    View in: PubMed
  305. Bhatt DL. Acute coronary syndrome update for hospitalists. J Hosp Med. 2010 Sep; 5 Suppl 4:S15-21.
    View in: PubMed
  306. Bangalore S, Bhatt DL, Röther J, Alberts MJ, Thornton J, Wolski K, Goto S, Hirsch AT, Smith SC, Aichner FT, Topakian R, Cannon CP, Steg PG. Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation. 2010 Sep 14; 122(11):1091-100.
    View in: PubMed
  307. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, Wilson PW, Alberts MJ, D'Agostino R, Liau CS, Mas JL, Röther J, Smith SC, Salette G, Contant CF, Massaro JM, Steg PG. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010 Sep 22; 304(12):1350-7.
    View in: PubMed
  308. Goto S, Ogawa H, Takeuchi M, Flather MD, Bhatt DL. Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease. Eur Heart J. 2010 Nov; 31(21):2601-13.
    View in: PubMed
  309. Paré G, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Hirsh J, Simonsen K, Bhatt DL, Fox KA, Eikelboom JW. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med. 2010 Oct 28; 363(18):1704-14.
    View in: PubMed
  310. Kumbhani DJ, Bhatt DL. Platelet activation: yet another strike against routine TRANSFUSION. Eur Heart J. 2010 Nov; 31(22):2712-4.
    View in: PubMed
  311. Topol EJ, Bousser MG, Fox KA, Creager MA, Despres JP, Easton JD, Hamm CW, Montalescot G, Steg PG, Pearson TA, Cohen E, Gaudin C, Job B, Murphy JH, Bhatt DL. Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet. 2010 Aug 14; 376(9740):517-23.
    View in: PubMed
  312. Suárez C, Zeymer U, Limbourg T, Baumgartner I, Cacoub P, Poldermans D, Röther J, Bhatt DL, Steg PG. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry. Vasc Med. 2010 Aug; 15(4):259-65.
    View in: PubMed
  313. Beygui F, Silvain J, Pena A, Bellemain-Appaix A, Collet JP, Drexler H, Bhatt D, Vicaut E, Montalescot G. Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates. Am J Cardiol. 2010 Sep 1; 106(5):650-8.
    View in: PubMed
  314. Depta JP, Bhatt DL. Atherothrombosis and atrial fibrillation: Important and often overlapping clinical syndromes. Thromb Haemost. 2010 Oct; 104(4):657-63.
    View in: PubMed
  315. Gaxiola E, Eng-Ceceña L, Ortiz-Galván F, Llamas-López L, Rangel-Guerra R, Alcocer-Gamba MA, Bhatt DL, Gabriel Steg P. Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH Registry. Clin Cardiol. 2010 Jul; 33(7):445-51.
    View in: PubMed
  316. Leonardi S, Rao SV, Harrington RA, Bhatt DL, Gibson CM, Roe MT, Kochman J, Huber K, Zeymer U, Madan M, Gretler DD, McClure MW, Paynter GE, Thompson V, Welsh RC. Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI). Am Heart J. 2010 Jul; 160(1):65-72.
    View in: PubMed
  317. Hankey GJ, Hacke W, Easton JD, Johnston SC, Mas JL, Brennan DM, Bhatt DL, Fox KA, Topol EJ. Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial. Stroke. 2010 Aug; 41(8):1679-83.
    View in: PubMed
  318. Bhatt DL. Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not. JAMA. 2010 Jun 2; 303(21):2188-9.
    View in: PubMed
  319. Desai NR, Bhatt DL. The state of periprocedural antiplatelet therapy after recent trials. JACC Cardiovasc Interv. 2010 Jun; 3(6):571-83.
    View in: PubMed
  320. Berger PB, Bhatt DL, Fuster V, Steg PG, Fox KA, Shao M, Brennan DM, Hacke W, Montalescot G, Steinhubl SR, Topol EJ. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation. 2010 Jun 15; 121(23):2575-83.
    View in: PubMed
  321. Kolandaivelu K, Bhatt DL. Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence. Nat Rev Cardiol. 2010 Aug; 7(8):461-7.
    View in: PubMed
  322. Boden WE, Flather MD, Bhatt DL. Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspective. Cardiovasc Drugs Ther. 2010 Jun; 24(3):207-16.
    View in: PubMed
  323. Geisler T, Gawaz M, Steinhubl SR, Bhatt DL, Storey RF, Flather M. Current strategies in antiplatelet therapy--does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease? Pharmacol Ther. 2010 Aug; 127(2):95-107.
    View in: PubMed
  324. Kashyap SR, Bhatt DL, Schauer PR. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab. 2010 May; 12(5):452-4.
    View in: PubMed
  325. Glauser J, Emerman CL, Bhatt DL, Peacock WF. Platelet aspirin resistance in ED patients with suspected acute coronary syndrome. Am J Emerg Med. 2010 May; 28(4):440-4.
    View in: PubMed
  326. Winkel TA, Hoeks SE, Schouten O, Zeymer U, Limbourg T, Baumgartner I, Bhatt DL, Steg PG, Goto S, Röther J, Cacoub PP, Verhagen HJ, Bax JJ, Poldermans D. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Eur J Vasc Endovasc Surg. 2010 Jul; 40(1):9-16.
    View in: PubMed
  327. Dauerman HL, Bhatt DL, Gretler DD, French PA, Smyth SS, Becker RC. Bridging the gap between clinical trials of antiplatelet therapies and applications among elderly patients. Am Heart J. 2010 Apr; 159(4):508-517.e1.
    View in: PubMed
  328. Ademi Z, Walls HL, Peeters A, Liew D, Hollingsworth B, Stevenson C, Steg PG, Bhatt DL, Reid CM. Economic implications of obesity among people with atherothrombotic disease. Int J Obes (Lond). 2010 Aug; 34(8):1284-92.
    View in: PubMed
  329. Krempf M, Parhofer KG, Steg PG, Bhatt DL, Ohman EM, Röther J, Goto S, Pasquet B, Wilson PW. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol. 2010 Mar 1; 105(5):667-71.
    View in: PubMed
  330. Sakhuja R, Yeh RW, Bhatt DL. Antiplatelet agents in acute coronary syndromes. Curr Probl Cardiol. 2010 Mar; 35(3):123-70.
    View in: PubMed
  331. Arepally G, Bauer KA, Bhatt DL, Merli GJ, Naccarelli GV, Carter RD, Karcher RB, Berry CA, Keaton KL, Stowell SA. The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education. Crit Pathw Cardiol. 2010 Mar; 9(1):41-8.
    View in: PubMed
  332. Ducrocq G, Wallace JS, Baron G, Ravaud P, Alberts MJ, Wilson PW, Ohman EM, Brennan DM, D'Agostino RB, Bhatt DL, Steg PG. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J. 2010 May; 31(10):1257-65.
    View in: PubMed
  333. Bhatt DL. Controversies in non-ST-elevation acute coronary syndromes and percutaneous coronary interventions. Cleve Clin J Med. 2010 Feb; 77(2):101-9.
    View in: PubMed
  334. Depta JP, Bhatt DL. Omeprazole and clopidogrel: Should clinicians be worried? Cleve Clin J Med. 2010 Feb; 77(2):113-6.
    View in: PubMed
  335. Cannon CP, Rhee KE, Califf RM, Boden WE, Hirsch AT, Alberts MJ, Cable G, Shao M, Ohman EM, Steg PG, Eagle KA, Bhatt DL. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol. 2010 Feb 15; 105(4):445-52.
    View in: PubMed
  336. Ademi Z, Liew D, Hollingsworth B, Steg PG, Bhatt DL, Reid CM. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry. Am J Cardiovasc Drugs. 2010; 10(2):85-94.
    View in: PubMed
  337. Ademi Z, Liew D, Hollingsworth B, Wolfe R, Steg GP, Bhatt DL, Reid CM. The economic implications of treating atherothrombotic disease in Australia, from the government perspective. Clin Ther. 2010 Jan; 32(1):119-32; discussion 106-7.
    View in: PubMed
  338. Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV, Manoukian SV, Widimsky P, Chew DP, Cura F, Manukov I, Tousek F, Jafar MZ, Arneja J, Skerjanec S, Harrington RA. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med. 2009 Dec 10; 361(24):2330-41.
    View in: PubMed
  339. Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RC, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL. Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med. 2009 Dec 10; 361(24):2318-29.
    View in: PubMed
  340. Bhatt DL. Antiplatelet therapy: Ticagrelor in ACS-what does PLATO teach us? Nat Rev Cardiol. 2009 Dec; 6(12):737-8.
    View in: PubMed
  341. Meadows TA, Bhatt DL, Hirsch AT, Creager MA, Califf RM, Ohman EM, Cannon CP, Eagle KA, Alberts MJ, Goto S, Smith SC, Wilson PW, Watson KE, Steg PG. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Am Heart J. 2009 Dec; 158(6):1038-45.
    View in: PubMed
  342. Mechtouff L, Touzé E, Steg PG, Ohman EM, Goto S, Hirsch AT, Röther J, Aichner FT, Weimar C, Bhatt DL, Alberts MJ, Mas JL. Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease. J Intern Med. 2010 Jun; 267(6):621-33.
    View in: PubMed
  343. Kumbhani DJ, Cannon CP, Fonarow GC, Liang L, Askari AT, Peacock WF, Peterson ED, Bhatt DL. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009 Nov 25; 302(20):2207-13.
    View in: PubMed
  344. Berger JS, Bhatt DL, Steinhubl SR, Shao M, Steg PG, Montalescot G, Hacke W, Fox KA, Lincoff AM, Topol EJ, Berger PB. Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation. 2009 Dec 8; 120(23):2337-44.
    View in: PubMed
  345. Berger JS, Bhatt DL, Cannon CP, Chen Z, Jiang L, Jones JB, Mehta SR, Sabatine MS, Steinhubl SR, Topol EJ, Berger PB. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis. J Am Coll Cardiol. 2009 Nov 17; 54(21):1935-45.
    View in: PubMed
  346. Depta JP, Cannon CP, Fonarow GC, Zhao X, Peacock WF, Bhatt DL. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes. Am J Cardiol. 2009 Nov 1; 104(9):1171-8.
    View in: PubMed
  347. Parhofer KG, Zeymer U, Stark RG, Binz C, Schwertfeger M, Bhatt DL, Steg PG, Röther J. In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry. Exp Clin Endocrinol Diabetes. 2010 Jan; 118(1):51-6.
    View in: PubMed
  348. Uchiyama S, Goto S, Matsumoto M, Nagai R, Origasa H, Yamazaki T, Shigematsu H, Shimada K, Yamada N, Bhatt DL, Steg PG, Ikeda Y. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry. J Neurol Sci. 2009 Dec 15; 287(1-2):45-51.
    View in: PubMed
  349. Wang TD, Goto S, Bhatt DL, Steg PG, Chan JC, Richard AJ, Liau CS. Ethnic differences in the relationships of anthropometric measures to metabolic risk factors in Asian patients at risk of atherothrombosis: results from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Metabolism. 2010 Mar; 59(3):400-8.
    View in: PubMed
  350. Shishehbor MH, Hawi R, Singh IM, Tuzcu EM, Bhatt DL, Ellis SG, Kapadia SR. Drug-eluting versus bare-metal stents for treating saphenous vein grafts. Am Heart J. 2009 Oct; 158(4):637-43.
    View in: PubMed
  351. Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Crit Pathw Cardiol. 2009 Sep; 8(3):104-11.
    View in: PubMed
  352. Wang TY, Newby LK, Chen AY, Mulgund J, Roe MT, Sonel AF, Bhatt DL, DeLong ER, Ohman EM, Gibler WB, Peterson ED. Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome. Clin Cardiol. 2009 Sep; 32(9):E22-8.
    View in: PubMed
  353. Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, Röther J, Salette G, Goto S, Smith SC, Liau CS, Wilson PW, Steg PG. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J. 2009 Oct; 30(19):2318-26.
    View in: PubMed
  354. Bhatt DL. Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit? JAMA. 2009 Aug 26; 302(8):896-7.
    View in: PubMed
  355. Montalescot G, Drexler H, Gallo R, Pearson T, Thoenes M, Bhatt DL. Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study. Eur Heart J. 2009 Nov; 30(22):2733-41.
    View in: PubMed
  356. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010 Jan; 8(1):148-56.
    View in: PubMed
  357. Lee JY, Bhatt D, Bhatt D, Chung WY, Cooper RL. Furthering pharmacological and physiological assessment of the glutamatergic receptors at the Drosophila neuromuscular junction. Comp Biochem Physiol C Toxicol Pharmacol. 2009 Nov; 150(4):546-57.
    View in: PubMed
  358. Cooper RJ, Bhatt D, Everdell NL, Hebden JC. A tissue-like optically turbid and electrically conducting phantom for simultaneous EEG and near-infrared imaging. Phys Med Biol. 2009 Sep 21; 54(18):N403-8.
    View in: PubMed
  359. Brilakis ES, Hernandez AF, Dai D, Peterson ED, Banerjee S, Fonarow GC, Cannon CP, Bhatt DL. Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program. Circulation. 2009 Aug 18; 120(7):560-7.
    View in: PubMed
  360. Desai NR, Bhatt DL. Evaluating percutaneous support for cardiogenic shock: data shock and sticker shock. Eur Heart J. 2009 Sep; 30(17):2073-5.
    View in: PubMed
  361. Bhatt DL. Prasugrel in clinical practice. N Engl J Med. 2009 Sep 3; 361(10):940-2.
    View in: PubMed
  362. Serebruany VL, Kogushi M, Dastros-Pitei D, Flather M, Bhatt DL. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease. Thromb Haemost. 2009 Jul; 102(1):111-9.
    View in: PubMed
  363. Dumaine RL, Montalescot G, Steg PG, Ohman EM, Eagle K, Bhatt DL. Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J. 2009 Jul; 158(1):141-148.e1.
    View in: PubMed
  364. Singh J, Bhatt DL. Refining the role of antiplatelet therapy for atrial fibrillation. Curr Cardiol Rep. 2009 Jul; 11(4):239-40.
    View in: PubMed
  365. Chhatriwalla AK, Cam A, Unzek S, Bhatt DL, Raymond RE, Lincoff AM, Whitlow PL, Ellis SG, Tuzcu EM, Kapadia SR. Drug-eluting stent fracture and acute coronary syndrome. Cardiovasc Revasc Med. 2009 Jul-Sep; 10(3):166-71.
    View in: PubMed
  366. Collet JP, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Hu TF, Johnston SC, Hamm CW, Bhatt DL, Topol EJ. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial. Arch Cardiovasc Dis. 2009 Jun-Jul; 102(6-7):485-96.
    View in: PubMed
  367. Dhoble A, Patel MB, Abdelmoneim SS, Puttarajappa C, Abela GS, Bhatt DL, Thakur RK. Relation of porphyria to atrial fibrillation. Am J Cardiol. 2009 Aug 1; 104(3):373-6.
    View in: PubMed
  368. Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Steg PG, Cannon CP, Brennan DM, Bhatt DL. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry. Crit Pathw Cardiol. 2009 Jun; 8(2):91-7.
    View in: PubMed
  369. Roukoz H, Bavry AA, Sarkees ML, Mood GR, Kumbhani DJ, Rabbat MG, Bhatt DL. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am J Med. 2009 Jun; 122(6):581.e1-10.
    View in: PubMed
  370. Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, Fox KA, Goodman SG, Harrington RA, Huber K, Husted S, Lewis BS, Lopez-Sendon J, Mohan P, Montalescot G, Ruda M, Ruzyllo W, Verheugt F, Wallentin L. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial. Circulation. 2009 Jun 9; 119(22):2877-85.
    View in: PubMed
  371. Belkin M, Bhatt DL. Carotid stenting in the elderly: is 80 the new 60? Circulation. 2009 May 5; 119(17):2302-4.
    View in: PubMed
  372. Shishehbor MH, Filby SJ, Chhatriwalla AK, Christofferson RD, Jain A, Kapadia SR, Lincoff AM, Bhatt DL, Ellis SG. Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia. JACC Cardiovasc Interv. 2009 Apr; 2(4):329-36.
    View in: PubMed
  373. Bhatt DL, Kottke-Marchant K, Alexander JH, Peacock WF, Sabatine MS. Platelet response in practice: Applying new insights and tools for testing and treatment. Cleve Clin J Med. 2009 Apr; 76 Suppl 1:S24-32.
    View in: PubMed
  374. Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM, Kleiman NS, Brindis RG, Peacock WF, Brener SJ, Menon V, Smith SC, Pollack CV, Gibler WB, Ohman EM, Roe MT. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J. 2009 May; 30(10):1195-202.
    View in: PubMed
  375. Dasgupta A, Steinhubl SR, Bhatt DL, Berger PB, Shao M, Mak KH, Fox KA, Montalescot G, Weber MA, Haffner SM, Dimas AP, Steg PG, Topol EJ. Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial). Am J Cardiol. 2009 May 15; 103(10):1359-63.
    View in: PubMed
  376. Sakhuja R, Bhatt DL. Getting real with drug-eluting stents: 5-year follow up of a real-world cohort. Am Heart J. 2009 May; 157(5):802-4.
    View in: PubMed
  377. Aichner FT, Topakian R, Alberts MJ, Bhatt DL, Haring HP, Hill MD, Montalescot G, Goto S, Touzé E, Mas JL, Steg PG, Röther J. High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry. Eur J Neurol. 2009 Aug; 16(8):902-8.
    View in: PubMed
  378. Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, Berger PB, Topol EJ. Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med. 2009 Mar 17; 150(6):379-86.
    View in: PubMed
  379. Chen J, Bhatt DL, Dunn ES, Shi C, Caro JJ, Mahoney EM, Gabriel S, Jackson JD, Topol EJ, Cohen DJ. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial. Value Health. 2009 Sep; 12(6):872-9.
    View in: PubMed
  380. Mak KH, Bhatt DL, Shao M, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Topol EJ. The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J. 2009 Apr; 30(7):857-65.
    View in: PubMed
  381. Mehta C, Gao P, Bhatt DL, Harrington RA, Skerjanec S, Ware JH. Optimizing trial design: sequential, adaptive, and enrichment strategies. Circulation. 2009 Feb 3; 119(4):597-605.
    View in: PubMed
  382. Angiolillo DJ, Bhatt DL, Gurbel PA, Jennings LK. Advances in antiplatelet therapy: agents in clinical development. Am J Cardiol. 2009 Feb 2; 103(3 Suppl):40A-51A.
    View in: PubMed
  383. Bhatt DL. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease. Am J Cardiol. 2009 Feb 2; 103(3 Suppl):11A-19A.
    View in: PubMed
  384. Brener SJ, Bhatt DL. The pain and the gain of treating patients with acute coronary syndromes-can the two be separated? Am Heart J. 2009 Mar; 157(3):399-401.
    View in: PubMed
  385. Sakhuja R, Keebler M, Lai TS, McLaughlin Gavin C, Thakur R, Bhatt DL. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol. 2009 Mar 1; 103(5):735-41.
    View in: PubMed
  386. Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J. 2009 Jan; 30(2):192-201.
    View in: PubMed
  387. Sarkees ML, Bavry AA, Galla JM, Bhatt DL. Bare metal stent thrombosis 13 years after implantation. Cardiovasc Revasc Med. 2009 Jan-Mar; 10(1):58-9.
    View in: PubMed
  388. Bainey KR, Bhatt DL. Acute pericarditis: appendicitis of the heart? Mayo Clin Proc. 2009; 84(1):5-6.
    View in: PubMed
  389. Ademi Z, Liew D, Chew D, Conner G, Shiel L, Nelson M, Soman A, Steg G, Bhatt DL, Reid C. Drug treatment and cost of cardiovascular disease in Australia. Cardiovasc Ther. 2009; 27(3):164-72.
    View in: PubMed
  390. Chhatriwalla AK, Bhatt DL. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely. Circ Cardiovasc Interv. 2008 Dec; 1(3):217-25.
    View in: PubMed
  391. Bhatt DL. Resisting the temptation to oversimplify antiplatelet resistance. JACC Cardiovasc Interv. 2008 Dec; 1(6):660-2.
    View in: PubMed
  392. Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL, Wilson PW, Mas JL, Röther J. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke. 2009 Feb; 40(2):350-4.
    View in: PubMed
  393. Mehta RH, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, Röther J, Wilson PW, Richard AJ, Eagle KA, Ohman EM. Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J. 2008 Dec; 29(24):3052-60.
    View in: PubMed
  394. Mak KH, Bhatt DL, Shao M, Hankey GJ, Easton JD, Fox KA, Topol EJ. Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. Am Heart J. 2009 Apr; 157(4):658-65.
    View in: PubMed
  395. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, Goto S, Röther J, Steg PG, Hirsch AT. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis. 2009 Jun; 204(2):e86-92.
    View in: PubMed
  396. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008 Oct 28; 52(18):1502-17.
    View in: PubMed
  397. Eikelboom JW, Hankey GJ, Thom J, Bhatt DL, Steg PG, Montalescot G, Johnston SC, Steinhubl SR, Mak KH, Easton JD, Hamm C, Hu T, Fox KA, Topol EJ. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation. 2008 Oct 21; 118(17):1705-12.
    View in: PubMed
  398. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2008 Nov; 103(11):2890-907.
    View in: PubMed
  399. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2008 Oct 28; 118(18):1894-909.
    View in: PubMed
  400. Bhatt DL. Is it time to switch to radial access? J Invasive Cardiol. 2008 Oct; 20(10):A6, A8, A14.
    View in: PubMed
  401. Bhatt DL. Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention. Curr Atheroscler Rep. 2008 Oct; 10(5):367-8.
    View in: PubMed
  402. Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostino R, Ohman EM, Liau CS, Hirsch AT, Mas JL, Wilson PW, Corbalán R, Aichner F, Steg PG. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008 Nov; 156(5):855-63, 863.e2.
    View in: PubMed
  403. Shishehbor MH, Goel SS, Kapadia SR, Bhatt DL, Kelly P, Raymond RE, Galla JM, Brener SJ, Whitlow PL, Ellis SG. Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality. J Am Coll Cardiol. 2008 Sep 23; 52(13):1041-8.
    View in: PubMed
  404. Bhatt DL. What makes platelets angry: diabetes, fibrinogen, obesity, and impaired response to antiplatelet therapy? J Am Coll Cardiol. 2008 Sep 23; 52(13):1060-1.
    View in: PubMed
  405. Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J. 2008 Dec; 29(24):2989-3001.
    View in: PubMed
  406. Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, Mosse F, Jackson JD, Steg PG, Bhatt DL. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2008 Sep; 1(1):38-45.
    View in: PubMed
  407. Helton TJ, Bavry AA, Rajagopal V, Anderson RD, Yadav JS, Bhatt DL. The optimal treatment of carotid atherosclerosis: a 2008 update and literature review. Postgrad Med. 2008 Sep; 120(3):103-12.
    View in: PubMed
  408. Pottenger BC, Diercks DB, Bhatt DL. Regionalization of care for ST-segment elevation myocardial infarction: is it too soon? Ann Emerg Med. 2008 Dec; 52(6):677-685.
    View in: PubMed
  409. Mood GR, Bavry AA, Bhatt DL. Clopidogrel and coronary stents: risks and benefits. Curr Atheroscler Rep. 2008 Aug; 10(4):303-8.
    View in: PubMed
  410. Baumgartner I, Hirsch AT, Abola MT, Cacoub PP, Poldermans D, Steg PG, Creager MA, Bhatt DL. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Vasc Surg. 2008 Oct; 48(4):808-14.
    View in: PubMed
  411. Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O'Hagan P, Montalescot G, Ballantyne CM, Cannon CP. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J. 2008 Oct; 156(4):719-27.
    View in: PubMed
  412. Mehran R, Brodie B, Cox DA, Grines CL, Rutherford B, Bhatt DL, Dangas G, Feit F, Ohman EM, Parise H, Fahy M, Lansky AJ, Stone GW. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. Am Heart J. 2008 Jul; 156(1):44-56.
    View in: PubMed
  413. Bavry AA, Bhatt DL. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet. 2008 Jun 21; 371(9630):2134-43.
    View in: PubMed
  414. Shishehbor MH, Amini R, Oliveria LP, Singh IM, Kelly P, Bhatt DL, Kapadia SR, Ellis SG, Whitlow PL, Brener SJ. Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008 Jun; 1(3):227-32.
    View in: PubMed
  415. Bhatt DL, Pashkow FJ. Introduction. Oxidative stress and heart disease. Am J Cardiol. 2008 May 22; 101(10A):1D-2D.
    View in: PubMed
  416. Bhatt DL. Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. Am J Cardiol. 2008 May 22; 101(10A):4D-13D.
    View in: PubMed
  417. Madhwal S, Rajagopal V, Bhatt DL, Bajzer CT, Whitlow P, Kapadia SR. Predictors of difficult carotid stenting as determined by aortic arch angiography. J Invasive Cardiol. 2008 May; 20(5):200-4.
    View in: PubMed
  418. Chhatriwalla AK, Bhatt DL. Breaking with tradition: is diagnostic angiography really necessary before primary PCI? J Invasive Cardiol. 2008 May; 20(5):229-30.
    View in: PubMed
  419. Nissen SE, Nicholls SJ, Wolski K, Rodés-Cabau J, Cannon CP, Deanfield JE, Després JP, Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA. 2008 Apr 2; 299(13):1547-60.
    View in: PubMed
  420. Bavry AA, Raymond RE, Bhatt DL, Chambers CE, DeNardo AJ, Hermiller JB, Myers PR, Pitts DE, Scott JA, Savader SJ, Steinhubl S. Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device. J Invasive Cardiol. 2008 Apr; 20(4):152-6.
    View in: PubMed
  421. Bakhru MR, Bhatt DL. Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin? Cleve Clin J Med. 2008 Apr; 75(4):289-95.
    View in: PubMed
  422. Bhatt DL. Is prasugrel superior to clopidogrel for patients with acute coronary syndromes undergoing PCI? Nat Clin Pract Cardiovasc Med. 2008 May; 5(5):252-3.
    View in: PubMed
  423. Röther J, Alberts MJ, Touzé E, Mas JL, Hill MD, Michel P, Bhatt DL, Aichner FT, Goto S, Matsumoto M, Ohman EM, Okada Y, Uchiyama S, D'Agostino R, Hirsch AT, Wilson PW, Steg PG. Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc Dis. 2008; 25(4):366-74.
    View in: PubMed
  424. Shishehbor MH, Amini R, Raymond RE, Bavry AA, Brener SJ, Kapadia SR, Whitlow PL, Ellis SG, Bhatt DL. Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents. Am Heart J. 2008 Jun; 155(6):1075-80.
    View in: PubMed
  425. Bhatt DL. Percutaneous coronary intervention in nonagenarians: age before beauty? Catheter Cardiovasc Interv. 2008 Mar 1; 71(4):531-2.
    View in: PubMed
  426. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Antiplatelet therapy and platelet function testing. Clin Cardiol. 2008 Mar; 31(3 Suppl 1):I36.
    View in: PubMed
  427. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes. Clin Cardiol. 2008 Mar; 31(3 Suppl 1):I2-9.
    View in: PubMed
  428. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Investigating the mechanisms of hyporesponse to antiplatelet approaches. Clin Cardiol. 2008 Mar; 31(3 Suppl 1):I21-7.
    View in: PubMed
  429. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention. Clin Cardiol. 2008 Mar; 31(3 Suppl 1):I28-35.
    View in: PubMed
  430. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Antiplatelet therapy and platelet function testing. Introduction. Clin Cardiol. 2008 Mar; 31(3 Suppl 1):I1.
    View in: PubMed
  431. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Assessing the current role of platelet function testing. Clin Cardiol. 2008 Mar; 31(3 Suppl 1):I10-6.
    View in: PubMed
  432. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention. Clin Cardiol. 2008 Mar; 31(3 Suppl 1):I17-20.
    View in: PubMed
  433. Hart RG, Bhatt DL, Hacke W, Fox KA, Hankey GJ, Berger PB, Hu T, Topol EJ. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial. Cerebrovasc Dis. 2008; 25(4):344-7.
    View in: PubMed
  434. Kumbhani DJ, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL. The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials. Am Heart J. 2008 Apr; 155(4):640-7.
    View in: PubMed
  435. Shishehbor MH, Bhatt DL. Treating patients with non-STEMI: stent the culprit artery only or address all lesions? Curr Treat Options Cardiovasc Med. 2008 Feb; 10(1):93-7.
    View in: PubMed
  436. Depta JP, Bhatt DL. Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance. Am J Cardiovasc Drugs. 2008; 8(2):91-112.
    View in: PubMed
  437. Peacock WF, Bhatt DL, Diercks D, Amsterdam E, Chandra A, Ohman EM, Brown DF, Januzzi J. Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines pertaining to ST-segment-elevation myocardial infarction. Tex Heart Inst J. 2008; 35(2):152-61.
    View in: PubMed
  438. Brener SJ, Milford-Beland S, Roe MT, Bhatt DL, Weintraub WS, Brindis RG. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. Am Heart J. 2008 Jan; 155(1):140-6.
    View in: PubMed
  439. Novaro GM, Asher CR, Bhatt DL, Moliterno DJ, Harrington RA, Lincoff AM, Newby LK, Tcheng JE, Hsu AP, Pinski SL. Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites. Am J Cardiol. 2008 Feb 15; 101(4):506-9.
    View in: PubMed
  440. Bhatt DL. Intensifying platelet inhibition--navigating between Scylla and Charybdis. N Engl J Med. 2007 Nov 15; 357(20):2078-81.
    View in: PubMed
  441. Mood GR, Bhatt DL. Clopidogrel and risk for acute coronary events. Curr Atheroscler Rep. 2007 Nov; 9(5):401-8.
    View in: PubMed
  442. Brotman DJ, Bakhru M, Saber W, Aneja A, Bhatt DL, Tillan-Martinez K, Jaffer AK. Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study. J Hosp Med. 2007 Nov; 2(6):378-84.
    View in: PubMed
  443. Medina HM, Bhatt DL. Evolution of anticoagulant and antiplatelet therapy: benefits and risks of contemporary pharmacologic agents and their implications for myonecrosis and bleeding in percutaneous coronary intervention. Clin Cardiol. 2007 Oct; 30(10 Suppl 2):II4-15.
    View in: PubMed
  444. Bhatt DL. Interpreting the COURAGE trial. Is medical therapy as good as PCI in stable angina? Two views. Cleve Clin J Med. 2007 Sep; 74(9):618, 620.
    View in: PubMed
  445. Bavry AA, Bhatt DL. Drug-eluting stents: dual antiplatelet therapy for every survivor? Circulation. 2007 Aug 14; 116(7):696-9.
    View in: PubMed
  446. Wang TH, Bhatt DL, Fox KA, Steinhubl SR, Brennan DM, Hacke W, Mak KH, Pearson TA, Boden WE, Steg PG, Flather MD, Montalescot G, Topol EJ. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. Eur Heart J. 2007 Sep; 28(18):2200-7.
    View in: PubMed
  447. Bavry AA, Bhatt DL. Designing the ideal risk model for acute coronary syndromes--is simple better than complex? Am Heart J. 2007 Aug; 154(2):206-7.
    View in: PubMed
  448. Doonan AL, Karha J, Carrigan TP, Bavry AA, Begelman SM, Ellis SG, Yadav J, Bhatt DL. Presence of carotid and peripheral arterial disease in patients with left main disease. Am J Cardiol. 2007 Oct 1; 100(7):1087-9.
    View in: PubMed
  449. Saw J, Brennan DM, Steinhubl SR, Bhatt DL, Mak KH, Fox K, Topol EJ. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol. 2007 Jul 24; 50(4):291-5.
    View in: PubMed
  450. Bhatt DL, Chew DP, Grines C, Mukherjee D, Leesar M, Gilchrist IC, Corbelli JC, Blankenship JC, Eres A, Steinhubl S, Tan WA, Resar JR, AlMahameed A, Abdel-Latif A, Wilson Tang WH, Tang HW, Brennan D, McErlean E, Hazen SL, Topol EJ. Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study. Am Heart J. 2007 Jul; 154(1):137-43.
    View in: PubMed
  451. Yamazaki T, Goto S, Shigematsu H, Shimada K, Uchiyama S, Nagai R, Yamada N, Matsumoto M, Origasa H, Bhatt DL, Steg PG, Ikeda Y. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J. 2007 Jul; 71(7):995-1003.
    View in: PubMed
  452. Mood GR, Bavry AA, Roukoz H, Bhatt DL. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention. Am J Cardiol. 2007 Sep 15; 100(6):919-23.
    View in: PubMed
  453. Steinberg BA, Ballantyne CM, Bhatt DL, Montalescot G, Mehta S, O'Hagan P, Poole-Wilson PA, Cannon CP. An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registry. Crit Pathw Cardiol. 2007 Jun; 6(2):72-5.
    View in: PubMed
  454. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007 May 22; 115(20):e478-534.
    View in: PubMed
  455. Cohen M, Bhatt DL, Alexander JH, Montalescot G, Bode C, Henry T, Tamby JF, Saaiman J, Simek S, De Swart J. Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial. Circulation. 2007 May 22; 115(20):2642-51.
    View in: PubMed
  456. Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res. 2007 May 11; 100(9):1261-75.
    View in: PubMed
  457. Glauser J, Erickson J, Bhatt D, Lindsell C, Gibler B, Hoekstra J, Pollack C, Hollander J, Peacock WF. Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry. Congest Heart Fail. 2007 May-Jun; 13(3):142-8.
    View in: PubMed
  458. Bavry AA, Bhatt DL. Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint? Am Heart J. 2007 May; 153(5):719-21.
    View in: PubMed
  459. Gurm HS, Rajagopal V, Bhatt DL, Ellis SG, Lincoff AM. The safety of a bivalirudin-based approach in patients undergoing rotational atherectomy. J Invasive Cardiol. 2007 May; 19(5):225-8.
    View in: PubMed
  460. Steinhubl SR, Badimon JJ, Bhatt DL, Herbert JM, Lüscher TF. Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med. 2007 May; 12(2):113-22.
    View in: PubMed
  461. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 May; 38(5):1655-711.
    View in: PubMed
  462. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007 May 15; 49(19):1982-8.
    View in: PubMed
  463. Steg PG, Bhatt DL, Wilson PW, D'Agostino R, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007 Mar 21; 297(11):1197-206.
    View in: PubMed
  464. Steinberg BA, Steg PG, Bhatt DL, Fonarow GC, Zeymer U, Cannon CP. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol. 2007 May 1; 99(9):1212-5.
    View in: PubMed
  465. Kumbhani DJ, Bavry AA, Bhatt DL. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Indian Heart J. 2007 Mar-Apr; 59(2 Suppl B):B113-7.
    View in: PubMed
  466. Abu Romeh IS, Chhatriwalla AK, Atik FA, Bhatt DL, Navia JL. Myocardial infarction secondary to a coronary ostial thrombus in antiphospholipid syndrome. Ann Thorac Surg. 2007 Mar; 83(3):1170-1.
    View in: PubMed
  467. Mehta RH, Milford-Beland S, Peterson ED, Bhatt DL, Farkouh ME, Brogan GX, Gibler WB, Ohman EM, Roe MT. Characterizing young patients with diabetes and non-ST-segment elevation acute coronary syndromes. Diabetes Care. 2007 Mar; 30(3):731-3.
    View in: PubMed
  468. Shishehbor MH, Lauer MS, Singh IM, Chew DP, Karha J, Brener SJ, Moliterno DJ, Ellis SG, Topol EJ, Bhatt DL. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol. 2007 Feb 27; 49(8):849-54.
    View in: PubMed
  469. Bavry AA, Chiu JH, Jefferson BK, Karha J, Bhatt DL, Ellis SG, Whitlow PL. Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med. 2007 Feb 6; 146(3):230-2.
    View in: PubMed
  470. Rabbat MG, Bavry AA, Bhatt DL, Ellis SG. Understanding and minimizing late thrombosis of drug-eluting stents. Cleve Clin J Med. 2007 Feb; 74(2):129-36.
    View in: PubMed
  471. Kelly P, Bhatt DL. Identification of vulnerable plaque--the quest continues. J Invasive Cardiol. 2007 Feb; 19(2):55-7.
    View in: PubMed
  472. Patel TN, Shishehbor MH, Bhatt DL. A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis. Eur Heart J. 2007 Mar; 28(6):664-72.
    View in: PubMed
  473. Bavry AA, Mood GR, Kumbhani DJ, Borek PP, Askari AT, Bhatt DL. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials. Am J Cardiovasc Drugs. 2007; 7(2):135-41.
    View in: PubMed
  474. John JM, Bhatt DL. Emerging risk factors for atherosclerosis. Indian Heart J. 2007 Jan-Feb; 59(1):28-37.
    View in: PubMed
  475. Rabbat MG, Bavry AA, Bhatt DL. Drug-eluting stents: can we move beyond stent thrombosis? Am Heart Hosp J. 2007; 5(3):155-8.
    View in: PubMed
  476. Helton TJ, Bavry AA, Kumbhani DJ, Duggal S, Roukoz H, Bhatt DL. Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials. Am J Cardiovasc Drugs. 2007; 7(4):289-97.
    View in: PubMed
  477. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006 Dec; 119(12):1056-61.
    View in: PubMed
  478. Chhatriwalla AK, Bhatt DL. Walk this way: early ambulation after cardiac catheterization--good for the patient and the health care system. Mayo Clin Proc. 2006 Dec; 81(12):1535-6.
    View in: PubMed
  479. Bhatt DL. Shifting the diagnosis of periprocedural myocardial infarction upstream. Circulation. 2006 Oct 31; 114(18):1898-900.
    View in: PubMed
  480. Touzé E, Mas JL, Röther J, Goto S, Hirsch AT, Ikeda Y, Liau CS, Ohman EM, Richard AJ, Wilson PW, Steg PG, Bhatt DL. Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Stroke. 2006 Dec; 37(12):2880-5.
    View in: PubMed
  481. Cannon CP, Bhatt DL. Clinical trials update from the annual scientific session of the American College of Cardiology 2006. Am J Cardiol. 2006 Dec 18; 98(12A):36Q-41Q.
    View in: PubMed
  482. Bhatt DL. Identification of and management approaches for the high-risk patient. Am J Cardiol. 2006 Dec 18; 98(12A):22Q-29Q.
    View in: PubMed
  483. Almahameed A, Bhatt DL. Contemporary management of peripheral arterial disease: III. Endovascular and surgical management. Cleve Clin J Med. 2006 Oct; 73 Suppl 4:S45-51.
    View in: PubMed
  484. Exaire JE, Fathi RB, Brener SJ, Karha J, Ellis SG, Bhatt DL. Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction. Arch Cardiol Mex. 2006 Oct-Dec; 76(4):376-82.
    View in: PubMed
  485. Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV, Brindis RG, Gibson CM, Kleiman NS, Saucedo JF, Bhatt DL, Gibler WB, Ohman EM, Harrington RA, Roe MT. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J. 2006 Oct; 152(4):641-7.
    View in: PubMed
  486. Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, Tcheng JE, Harrington RA, Simoons M, Hu T, Sheikh MA, Kereiakes DJ, Topol EJ. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006 Oct 17; 48(8):1567-72.
    View in: PubMed
  487. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006 Oct 3; 48(7):1319-25.
    View in: PubMed
  488. Bavry AA, Bhatt DL. Bare metal stents: no longer passé? J Invasive Cardiol. 2006 Sep; 18(9):403-4.
    View in: PubMed
  489. Tricoci P, Peterson ED, Mulgund J, Newby LK, Saucedo JF, Kleiman NS, Bhatt DL, Berger PB, Cannon CP, Cohen DJ, Hochman JS, Ohman EM, Gibler WB, Harrington RA, Smith SC, Roe MT. Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE). Am J Cardiol. 2006 Nov 1; 98(9):1172-6.
    View in: PubMed
  490. Karha J, Gurm HS, Rajagopal V, Fathi R, Bavry AA, Brener SJ, Lincoff AM, Ellis SG, Bhatt DL. Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes. Am J Cardiol. 2006 Oct 1; 98(7):906-10.
    View in: PubMed
  491. Serebruany VL, Malinin AI, Bhatt DL. Paradoxical rebound platelet activation after painkillers cessation: missing risk for vascular events? Am J Med. 2006 Aug; 119(8):707.e11-6.
    View in: PubMed
  492. Shishehbor MH, Patel T, Bhatt DL. Using statins to treat inflammation in acute coronary syndromes: Are we there yet? Cleve Clin J Med. 2006 Aug; 73(8):760-6.
    View in: PubMed
  493. Bhatheja R, Bhatt DL. Clinical outcomes in metabolic syndrome. J Cardiovasc Nurs. 2006 Jul-Aug; 21(4):298-305.
    View in: PubMed
  494. Bhatt DL. NSAIDS and the risk of myocardial infarction: do they help or harm? Eur Heart J. 2006 Jul; 27(14):1635-6.
    View in: PubMed
  495. Rajagopal V, Bhatt DL. Gaps in myocardial infarction care: how might we best EFFECT change? Eur Heart J. 2006 Jul; 27(13):1513-4.
    View in: PubMed
  496. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006 Jun; 151(6):1260-4.
    View in: PubMed
  497. Bavry AA, Bhatt DL. Interpreting observational studies -- look before you leap. J Clin Epidemiol. 2006 Aug; 59(8):763-4.
    View in: PubMed
  498. Barman N, Bhatt DL. Antithrombotic therapy for percutaneous coronary intervention. Cardiol Clin. 2006 May; 24(2):175-99, v-vi.
    View in: PubMed
  499. Karha J, Rajagopal V, Kottke-Marchant K, Bhatt DL. Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers. Am Heart J. 2006 May; 151(5):976.e7-11.
    View in: PubMed
  500. Tricoci P, Roe MT, Mulgund J, Newby LK, Smith SC, Pollack CV, Fintel DJ, Cannon CP, Bhatt DL, Gibler WB, Ohman EM, Peterson ED, Harrington RA. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge. Arch Intern Med. 2006 Apr 10; 166(7):806-11.
    View in: PubMed
  501. Bhatt DL. Can clopidogrel and aspirin lower mortality in patients with acute myocardial infarction? Nat Clin Pract Cardiovasc Med. 2006 Apr; 3(4):182-3.
    View in: PubMed
  502. Ellis SG, Bhatt D, Kapadia S, Lee D, Yen M, Whitlow PL. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006 Apr; 67(4):541-5.
    View in: PubMed
  503. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, Mas JL, Richard AJ, Röther J, Wilson PW. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006 Apr; 151(4):786.e1-10.
    View in: PubMed
  504. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006 Apr 20; 354(16):1706-17.
    View in: PubMed
  505. Chhatriwalla AK, Bhatt DL. You can't keep a good man (or woman) down. J Invasive Cardiol. 2006 Mar; 18(3):109-10.
    View in: PubMed
  506. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006 Apr 1; 97(7):993-6.
    View in: PubMed
  507. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PW. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 Jan 11; 295(2):180-9.
    View in: PubMed
  508. Serebruany VL, Pokov AN, Malinin AI, O'Connor C, Bhatt DL, Tanguay JF, Sane DC, Hennekens CH. Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trial. Am Heart J. 2006 Jan; 151(1):92-9.
    View in: PubMed
  509. Brogan GX, Peterson ED, Mulgund J, Bhatt DL, Ohman EM, Gibler WB, Pollack CV, Farkouh ME, Roe MT. Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. Diabetes Care. 2006 Jan; 29(1):9-14.
    View in: PubMed
  510. Bhatt DL. Clopidogrel bisulfate in st-segment elevation myocardial infarction: a viewpoint by Deepak L Bhatt. Am J Cardiovasc Drugs. 2006; 6(6):415.
    View in: PubMed
  511. Chew DP, Bhatt DL, Lincoff AM, Wolski K, Topol EJ. Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk. Heart. 2006 Jul; 92(7):945-50.
    View in: PubMed
  512. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J. 2006 Mar; 27(6):647-54.
    View in: PubMed
  513. Fathi RB, Gurm HS, Chew DP, Gupta R, Bhatt DL, Ellis SG. The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention. Am Heart J. 2005 Dec; 150(6):1190-7.
    View in: PubMed
  514. Bhatt D, Tu C, Fisher SZ, Hernandez Prada JA, McKenna R, Silverman DN. Proton transfer in a Thr200His mutant of human carbonic anhydrase II. Proteins. 2005 Nov 1; 61(2):239-45.
    View in: PubMed
  515. Ghaffari G, Tuttle DL, Briggs D, Burkhardt BR, Bhatt D, Andiman WA, Sleasman JW, Goodenow MM. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages. J Virol. 2005 Nov; 79(21):13250-61.
    View in: PubMed
  516. Selvaraj CL, Gurm HS, Gupta R, Ellis SG, Bhatt DL. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2005 Sep 15; 96(6):756-9.
    View in: PubMed
  517. Serebruany VL, Malinin AI, Ziai W, Pokov AN, Bhatt DL, Alberts MJ, Hanley DF. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial. Stroke. 2005 Oct; 36(10):2289-92.
    View in: PubMed
  518. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Booth J, Topol EJ. A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J. 2005 Sep; 150(3):401.
    View in: PubMed
  519. Chen MS, Bhatt DL, Chew DP, Moliterno DJ, Ellis SG, Topol EJ. Outcomes in African Americans and whites after percutaneous coronary intervention. Am J Med. 2005 Sep; 118(9):1019-25.
    View in: PubMed
  520. Ziada KM, Yadav JS, Mukherjee D, Lauer MS, Bhatt DL, Kapadia S, Roffi M, Vora N, Tiong I, Bajzer C. Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol. 2005 Aug 15; 96(4):519-23.
    View in: PubMed
  521. Aronow HD, Shishehbor M, Davis DA, Katzan IL, Bhatt DL, Bajzer CT, Abou-Chebl A, Derk KW, Whitlow PL, Yadav JS. Leukocyte count predicts microembolic Doppler signals during carotid stenting: a link between inflammation and embolization. Stroke. 2005 Sep; 36(9):1910-4.
    View in: PubMed
  522. Bhatt DL, Topol EJ. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation. 2005 Aug 9; 112(6):906-15; discussion 923.
    View in: PubMed
  523. Bhatt DL. To cath or not to cath: that is no longer the question. JAMA. 2005 Jun 15; 293(23):2935-7.
    View in: PubMed
  524. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). Am J Cardiol. 2005 Jun 15; 95(12):1469-72.
    View in: PubMed
  525. Fathi RB, Bhatt DL. Enhancing reperfusion therapy for myocardial infarction with dual antiplatelet therapy: Breaking the glass ceiling. Am Heart J. 2005 Jun; 149(6):947-9.
    View in: PubMed
  526. Rajagopal V, Bhatt DL. Acute coronary syndrome statistics: what you don't see can hurt you. Am Heart J. 2005 Jun; 149(6):955-6.
    View in: PubMed
  527. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Baggish JS, Bhatt DL, Topol EJ. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol. 2005 May 15; 95(10):1218-22.
    View in: PubMed
  528. Bhatt DL, Aranki S, Byrne J, Bhatia D, Mehta S, Mills R. Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion. J Invasive Cardiol. 2005 May; 17(5):283-7.
    View in: PubMed
  529. Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv. 2005 Apr; 64(4):442-8.
    View in: PubMed
  530. Gurm HS, Rajagopal V, Fathi R, Vivekanathan D, Yadav JS, Bhatt DL, Ellis SG, Lincoff AM, Topol EJ. Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center. Am J Cardiol. 2005 Mar 15; 95(6):716-21.
    View in: PubMed
  531. Chan AW, Yadav JS, Bhatt DL, Bajzer CT, Gum PA, Roffi M, Cho L, Agah R, Topol EJ. Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting. Am J Cardiol. 2005 Mar 15; 95(6):791-5.
    View in: PubMed
  532. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. J Am Coll Cardiol. 2005 Mar 15; 45(6):941-6.
    View in: PubMed
  533. Rajagopal V, Gurm HS, Brunken RC, Pothier CE, Bhatt DL, Lauer MS. Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting. Am Heart J. 2005 Mar; 149(3):534-40.
    View in: PubMed
  534. Karha J, Bhatt DL. Plaque regression--a new target for antiatherosclerotic therapy. Am Heart J. 2005 Mar; 149(3):384-7.
    View in: PubMed
  535. Rajagopal V, Bhatt DL. Factor Xa inhibitors in acute coronary syndromes: moving from mythology to reality. J Thromb Haemost. 2005 Mar; 3(3):436-8.
    View in: PubMed
  536. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol. 2005 Jan 18; 45(2):246-51.
    View in: PubMed
  537. Yen MH, Lee DS, Kapadia S, Sachar R, Bhatt DL, Bajzer CT, Yadav JS. Symptomatic patients have similar outcomes compared with asymptomatic patients after carotid artery stenting with emboli protection. Am J Cardiol. 2005 Jan 15; 95(2):297-300.
    View in: PubMed
  538. Gurm HS, Bhatt DL. Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors. Am Heart J. 2005 Jan; 149(1 Suppl):S43-53.
    View in: PubMed
  539. Duffy B, Bhatt DL. Antiplatelet agents in patients undergoing percutaneous coronary intervention: how many and how much? Am J Cardiovasc Drugs. 2005; 5(5):307-18.
    View in: PubMed
  540. Geisler T, Bhatt DL. The role of inflammation in atherothrombosis: current and future strategies of medical treatment. Med Sci Monit. 2004 Dec; 10(12):RA308-16.
    View in: PubMed
  541. Rajagopal V, Bhatt DL. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. Semin Thromb Hemost. 2004 Dec; 30(6):649-55.
    View in: PubMed
  542. Exaire JE, Brener SJ, Ellis SG, Yadav JS, Bhatt DL. GuardWire emboli protection device is associated with improved myocardial perfusion grade in saphenous vein graft intervention. Am Heart J. 2004 Dec; 148(6):1003-6.
    View in: PubMed
  543. Saw J, Bhatt DL. The evolving role of percutaneous intervention in coronary artery disease with coexistent aortic stenosis. J Invasive Cardiol. 2004 Dec; 16(12):692-3.
    View in: PubMed
  544. Chiu JH, Bhatt DL, Ziada KM, Chew DP, Whitlow PL, Lincoff AM, Ellis SG, Topol EJ. Impact of female sex on outcome after percutaneous coronary intervention. Am Heart J. 2004 Dec; 148(6):998-1002.
    View in: PubMed
  545. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC, Pollack CV, Gibler WB, Ohman EM. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004 Nov 3; 292(17):2096-104.
    View in: PubMed
  546. Hirsh J, Bhatt DL. Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. Arch Intern Med. 2004 Oct 25; 164(19):2106-10.
    View in: PubMed
  547. Saw J, Gurm HS, Fathi RB, Bhatt DL, Abou-Chebl A, Bajzer C, Yadav JS. Effect of chronic kidney disease on outcomes after carotid artery stenting. Am J Cardiol. 2004 Oct 15; 94(8):1093-6.
    View in: PubMed
  548. Ellis SG, Bajzer CT, Bhatt DL, Brener SJ, Whitlow PL, Lincoff AM, Moliterno DJ, Raymond RE, Tuzcu EM, Franco I, Dushman-Ellis S, Lander KJ, Schneider JP, Topol EJ. Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization. Catheter Cardiovasc Interv. 2004 Oct; 63(2):135-40.
    View in: PubMed
  549. Komadja M, Levy S, Steg PG, Bhatt DL. [New concepts in cardiology]. Presse Med. 2004 Sep 25; 33(16):1132-4.
    View in: PubMed
  550. Chacko M, Marrouche NF, Bhatt DL. Asymptomatic acute inferior ST elevation myocardial infarction from thermal injury complicating radiofrequency ablation for atrioventricular re-entrant tachycardia. J Invasive Cardiol. 2004 Sep; 16(9):504-5.
    View in: PubMed
  551. Bhatt DL. Peripheral arterial disease in the catheterization laboratory: an underdetected and undertreated risk factor. Mayo Clin Proc. 2004 Sep; 79(9):1107-9.
    View in: PubMed
  552. John JM, Bhatt DL. Management of acute coronary syndrome in diabetes mellitus. Herz. 2004 Aug; 29(5):532-41.
    View in: PubMed
  553. Bhatt DL, Topol EJ. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J. 2004 Aug; 148(2):263-8.
    View in: PubMed
  554. Vivekananthan DP, Bhatt DL, Chew DP, Zidar FJ, Chan AW, Moliterno DJ, Ellis SG, Topol EJ. Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. Am J Cardiol. 2004 Aug 1; 94(3):358-60.
    View in: PubMed
  555. Karha J, Bhatt DL. Percutaneous coronary intervention in diabetics. Rev Endocr Metab Disord. 2004 Aug; 5(3):277-85.
    View in: PubMed
  556. Rajagopal V, Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, Kereiakes DJ, Kleiman NS, Jia G, Topol EJ. Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. Am J Cardiol. 2004 Jul 15; 94(2):190-2.
    View in: PubMed
  557. Mills R, Bhatt DL. The Yin and Yang of arterial inflammation. J Am Coll Cardiol. 2004 Jul 7; 44(1):50-2.
    View in: PubMed
  558. Topol EJ, Bhatt DL, Simonton C, Steinhubl S, Lincoff AM. Here and now--state of the art: optimal antithrombotic strategy for percutaneous coronary intervention-panel discussion. J Invasive Cardiol. 2004 Jul; 16(7 Suppl):30S-31S.
    View in: PubMed
  559. Topol EJ, Bhatt DL, Penn M, Tuzcu EM, Herrmann H. The future--panel discussion. J Invasive Cardiol. 2004 Jul; 16(7 Suppl):65S-66S.
    View in: PubMed
  560. Bhatt DL. Bleeding complications during percutaneous coronary intervention. J Invasive Cardiol. 2004 Jul; 16(7 Suppl):24S-29S.
    View in: PubMed
  561. Bhatt DL. Emboli protection devices. J Invasive Cardiol. 2004 Jul; 16(7 Suppl):45S-49S.
    View in: PubMed
  562. Bhatt DL. Inflammation and restenosis: is there a link? Am Heart J. 2004 Jun; 147(6):945-7.
    View in: PubMed
  563. Abou-Chebl A, Yadav JS, Reginelli JP, Bajzer C, Bhatt D, Krieger DW. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol. 2004 May 5; 43(9):1596-601.
    View in: PubMed
  564. Sachar R, Yadav JS, Roffi M, Cho L, Reginelli JP, Aböu-Chebl A, Bhatt DL, Bajzer CT. Severe bilateral carotid stenosis: the impact of ipsilateral stenting on Doppler-defined contralateral stenosis. J Am Coll Cardiol. 2004 Apr 21; 43(8):1358-62.
    View in: PubMed
  565. Bhatt DL. Embolization--a pathological mechanism in renal artery stenosis. J Invasive Cardiol. 2004 Apr; 16(4):196-7.
    View in: PubMed
  566. Chen MS, Bhatt DL, Mukherjee D, Chan AW, Roffi M, Kapadia SR, Ziada KM, Chew DP, Bajzer CT, Yadav JS. Feasibility of simultaneous bilateral carotid artery stenting. Catheter Cardiovasc Interv. 2004 Apr; 61(4):437-42.
    View in: PubMed
  567. Quinn MJ, Aronow HD, Califf RM, Bhatt DL, Sapp S, Kleiman NS, Harrington RA, Kong DF, Kandzari DE, Topol EJ. Aspirin dose and six-month outcome after an acute coronary syndrome. J Am Coll Cardiol. 2004 Mar 17; 43(6):972-8.
    View in: PubMed
  568. Bhatt DL. Aspirin resistance: more than just a laboratory curiosity. J Am Coll Cardiol. 2004 Mar 17; 43(6):1127-9.
    View in: PubMed
  569. Quinn MJ, Bhatt DL, Zidar F, Vivekananthan D, Chew DP, Ellis SG, Plow E, Topol EJ. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2004 Mar 15; 93(6):679-84.
    View in: PubMed
  570. Tamberella MR, Yadav JS, Bajzer CT, Bhatt DL, Abou-Chebl A. Cutting balloon angioplasty to treat carotid in-stent restenosis. J Invasive Cardiol. 2004 Mar; 16(3):133-5.
    View in: PubMed
  571. Haery C, Exaire JE, Bhatt DL, Yadav JS, Franco I, Ellis SG. Use of PercuSurge GuardWire in native coronary arteries during acute myocardial infarction. J Invasive Cardiol. 2004 Mar; 16(3):152-4.
    View in: PubMed
  572. Shishehbor MH, Bhatt DL. Inflammation and atherosclerosis. Curr Atheroscler Rep. 2004 Mar; 6(2):131-9.
    View in: PubMed
  573. Lee DS, Bhatt DL, Moliterno DJ, Peacock WF, Ellis SG, Topol EJ. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients. J Invasive Cardiol. 2004 Feb; 16(2):46-51.
    View in: PubMed
  574. Merritt JC, Bhatt DL. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis. 2004 Feb; 17(1):21-7.
    View in: PubMed
  575. Ringleb PA, Bhatt DL, Hirsch AT, Topol EJ, Hacke W. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke. 2004 Feb; 35(2):528-32.
    View in: PubMed
  576. Maksimowicz-McKinnon K, Bhatt DL, Calabrese LH. Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers. Curr Opin Rheumatol. 2004 Jan; 16(1):18-24.
    View in: PubMed
  577. Cho L, Roffi M, Mukherjee D, Bhatt DL, Bajzer C, Yadav JS. Superficial femoral artery occlusion: nitinol stents achieve flow and reduce the need for medications better than balloon angioplasty alone. J Invasive Cardiol. 2004 Jan; 16 Suppl A:20A-22A.
    View in: PubMed
  578. Brener SJ, Bhatt DL, Moliterno DJ, Schneider JP, Ellis SG, Topol EJ. Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation. Am J Cardiol. 2003 Dec 15; 92(12):1468-71.
    View in: PubMed
  579. Jneid H, Bhatt DL. Advances in antiplatelet therapy. Expert Opin Emerg Drugs. 2003 Nov; 8(2):349-63.
    View in: PubMed
  580. Chew DP, Bhatt DL, Kimball W, Henry TD, Berger P, McCullough PA, Feit F, Bittl JA, Lincoff AM. Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. Am J Cardiol. 2003 Oct 15; 92(8):919-23.
    View in: PubMed
  581. Gurm HS, Bhatt DL, Gupta R, Ellis SG, Topol EJ, Lauer MS. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J. 2003 Oct; 146(4):692-8.
    View in: PubMed
  582. Hostetter JC, Bhatt DL. The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines. Minerva Cardioangiol. 2003 Oct; 51(5):531-46.
    View in: PubMed
  583. Chan AW, Moliterno DJ, Berger PB, Stone GW, DiBattiste PM, Yakubov SL, Sapp SK, Wolski K, Bhatt DL, Topol EJ. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol. 2003 Oct 1; 42(7):1188-95.
    View in: PubMed
  584. Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, Kereiakes DJ, Kleiman NS, Jia G, Topol EJ. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart. 2003 Oct; 89(10):1200-4.
    View in: PubMed
  585. Kereiakes DJ, Tcheng J, Fry ET, Bhatt DL, Bosker G, Diez JG, Ferguson JJ, Levine GN, Schaer GL, Zidar J. Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS. J Invasive Cardiol. 2003 Sep; 15(9):536-53.
    View in: PubMed
  586. Yen MH, Bhatt DL, Chew DP, Harrington RA, Newby LK, Ardissino D, Van de Werf F, White JA, Moliterno DJ, Topol EJ. Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. Am J Med. 2003 Sep; 115(4):318-21.
    View in: PubMed
  587. L'Allier PL, Aronow HD, Cura FA, Bhatt DL, Albirini A, Schneider JP, Topol EJ, Ellis SG. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting. Can J Cardiol. 2003 Aug; 19(9):1041-6.
    View in: PubMed
  588. Bhatt DL, Chew DP, Lincoff AM, Simoons ML, Harrington RA, Ommen SR, Jia G, Topol EJ. Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol. 2003 Jul 15; 92(2):136-40.
    View in: PubMed
  589. Shishehbor MH, Bhatt DL, Topol EJ. Using C-reactive protein to assess cardiovascular disease risk. Cleve Clin J Med. 2003 Jul; 70(7):634-40.
    View in: PubMed
  590. Jneid H, Bhatt DL, Corti R, Badimon JJ, Fuster V, Francis GS. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Arch Intern Med. 2003 May 26; 163(10):1145-53.
    View in: PubMed
  591. Chen MS, Bhatt DL. Highlights of the 2002 update to the 2000 American College of Cardiology/American Heart Association acute coronary syndrome guidelines. Cardiol Rev. 2003 May-Jun; 11(3):113-21.
    View in: PubMed
  592. Bhatt DL. Heparin in peripheral vascular intervention--time for a change? J Invasive Cardiol. 2003 May; 15(5):249-50.
    View in: PubMed
  593. Cho L, Roffi M, Mukherjee D, Bhatt DL, Bajzer C, Yadav JS. Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty alone. J Invasive Cardiol. 2003 Apr; 15(4):198-200.
    View in: PubMed
  594. Gerschutz GP, Bhatt DL. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: to what extent should the results be generalizable? Am Heart J. 2003 Apr; 145(4):595-601.
    View in: PubMed
  595. Chan AW, Bhatt DL, Chew DP, Reginelli J, Schneider JP, Topol EJ, Ellis SG. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation. 2003 Apr 8; 107(13):1750-6.
    View in: PubMed
  596. Cho L, Bhatt DL, Brennan D, Wilcox RG, Topol EJ. Relation of insurance status to performance of coronary angiography in patients with unstable angina pectoris or acute myocardial infarction. Am J Cardiol. 2003 Mar 15; 91(6):721-3.
    View in: PubMed
  597. Cho L, Chew DP, Moliterno DJ, Roffi M, Ellis SG, Franco I, Bajzer C, Bhatt DL, Dorosti K, Simpfendorder C, Tuzcu M, Yadav JS, Brener S, Raymond R, Whitlow P, Topol EJ, Lincoff AM. Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. Am J Cardiol. 2003 Mar 15; 91(6):742-3.
    View in: PubMed
  598. Bhatt DL. Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events. J Invasive Cardiol. 2003 Mar; 15 Suppl B:3B-9B; discussion 9B-10B.
    View in: PubMed
  599. Popma J, Bhatt DL. Case presentations and discussions. J Invasive Cardiol. 2003 Mar; 15 Suppl B:34B-41B.
    View in: PubMed
  600. Cho L, Bhatt DL, Marso SP, Brennan D, Holmes DR, Califf RM, Topol EJ. An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial. Am J Med. 2003 Feb 1; 114(2):106-11.
    View in: PubMed
  601. Francis GS, Bhatt DL. Ask the doctors. I live in a city with high air pollution. Is this a risk factor for heart disease? Heart Advis. 2003 Feb; 6(2):8.
    View in: PubMed
  602. Francis GS, Bhatt DL. Ask the doctors. My doctor said recently that I have pre-diabetes. What does that mean? Heart Advis. 2003 Feb; 6(2):8.
    View in: PubMed
  603. Francis GS, Bhatt DL. Ask the doctors. I have prominent varicose veins on both legs. They hurt, and I don't like how they look. How can I get rid of them? Heart Advis. 2003 Feb; 6(2):8.
    View in: PubMed
  604. Bhatt DL, Lee BI, Casterella PJ, Pulsipher M, Rogers M, Cohen M, Corrigan VE, Ryan TJ, Breall JA, Moses JW, Eaton GM, Sklar MA, Lincoff AM. Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study. J Am Coll Cardiol. 2003 Jan 1; 41(1):20-5.
    View in: PubMed
  605. Chan AW, Begelman SM, Bhatt DL. Percutaneous thrombin injection for pseudoaneurysm repair. Vasc Med. 2003; 8(3):217-8.
    View in: PubMed
  606. Chan AW, Roffi M, Mukherjee D, Bajzer CT, Abou-Chebl A, Ciezki J, Bhatt DL, Ghaffari S, Yadav JS. Carotid brachytherapy for in-stent restenosis. Catheter Cardiovasc Interv. 2003 Jan; 58(1):86-92.
    View in: PubMed
  607. Bhatt DL, Topol EJ. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov. 2003 Jan; 2(1):15-28.
    View in: PubMed
  608. Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM, Brennan DM, Ellis SG, Topol EJ. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation. 2002 Dec 10; 106(24):3063-7.
    View in: PubMed
  609. Reginelli JP, Bhatt DL. Why diabetics are at risk in percutaneous coronary intervention and the appropriate management of diabetics in interventional cardiology. J Invasive Cardiol. 2002 Dec; 14 Suppl E:2E-10E; quiz 11E.
    View in: PubMed
  610. Chan AW, Bhatt DL, Wilkoff BL, Roffi M, Mukherjee D, Gray BH, Baizer CT, Yadav JS. Percutaneous treatment for pacemaker-associated superior vena cava syndrome. Pacing Clin Electrophysiol. 2002 Nov; 25(11):1628-33.
    View in: PubMed
  611. Bhatt DL, Topol EJ. The arterial inflammation hypothesis. Arch Intern Med. 2002 Oct 28; 162(19):2249-50; author reply 2250-1.
    View in: PubMed
  612. Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol. 2002 Sep 15; 90(6):625-8.
    View in: PubMed
  613. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Moliterno DJ, Heeschen C, Hamm CW, Robbins MA, Kleiman NS, Théroux P, White HD, Topol EJ. Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. Eur Heart J. 2002 Sep; 23(18):1441-8.
    View in: PubMed
  614. Chan AW, Quinn MJ, Bhatt DL, Chew DP, Moliterno DJ, Topol EJ, Ellis SG. Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. J Am Coll Cardiol. 2002 Aug 21; 40(4):669-75.
    View in: PubMed
  615. Bhatt DL, Topol EJ. Need to test the arterial inflammation hypothesis. Circulation. 2002 Jul 2; 106(1):136-40.
    View in: PubMed
  616. Chew DP, Bhatt DL. Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials. Intern Med J. 2002 Jul; 32(7):338-45.
    View in: PubMed
  617. Tamberella MR, Bhatt DL, Chew DP, Kereiakes DJ, Topol EJ, Steinhubl SR. Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study). Am J Cardiol. 2002 Jun 15; 89(12):1429-31.
    View in: PubMed
  618. Aviles RJ, Bhatt DL. Antiplatelet therapies in combination for the treatment of patients with stable and unstable coronary artery disease. J Thromb Thrombolysis. 2002 Jun; 13(3):177-82.
    View in: PubMed
  619. Jeremias A, Bhatt DL, Chew DP, Ziada KM, Albirini A, Brener SJ, Lincoff AM, Topol EJ, Ellis SG. Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. Am J Cardiol. 2002 May 15; 89(10):1209-11.
    View in: PubMed
  620. Gerschutz GP, Bhatt DL. The CURE trial: using clopidogrel in acute coronary syndromes without ST-segment elevation. Cleve Clin J Med. 2002 May; 69(5):377-8, 380, 382 passim.
    View in: PubMed
  621. Merritt JC, Bhatt DL. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis. 2002 Apr; 13(2):97-103.
    View in: PubMed
  622. Bhatt DL, Raymond RE, Feldman T, Braden GA, Murphy B, Strumpf R, Rogers EW, Myla S, Knopf WD. Successful "pre-closure" of 7Fr and 8Fr femoral arteriotomies with a 6Fr suture-based device (the Multicenter Interventional Closer Registry). Am J Cardiol. 2002 Mar 15; 89(6):777-9.
    View in: PubMed
  623. Chan AW, Bhatt DL, Chew DP, Quinn MJ, Moliterno DJ, Topol EJ, Ellis SG. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation. 2002 Feb 12; 105(6):691-6.
    View in: PubMed
  624. Chan AW, Chew DP, Bhatt DL, Moliterno DJ, Topol EJ, Ellis SG. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2002 Jan 15; 89(2):132-6.
    View in: PubMed
  625. Bhatt DL, Bertrand ME, Berger PB, L'Allier PL, Moussa I, Moses JW, Dangas G, Taniuchi M, Lasala JM, Holmes DR, Ellis SG, Topol EJ. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol. 2002 Jan 2; 39(1):9-14.
    View in: PubMed
  626. Lauer MA, Houghtaling PL, Peterson JG, Granger CB, Bhatt DL, Sapp SK, Simoons ML, Harrington RA, Topol EJ, Lincoff AM. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation. 2001 Dec 4; 104(23):2772-7.
    View in: PubMed
  627. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, Hamm CW, Moliterno DJ, Califf RM, White HD, Kleiman NS, Théroux P, Topol EJ. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation. 2001 Dec 4; 104(23):2767-71.
    View in: PubMed
  628. Bhatt DL, Kapadia SR, Bajzer CT, Chew DP, Ziada KM, Mukherjee D, Roffi M, Topol EJ, Yadav JS. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. J Invasive Cardiol. 2001 Dec; 13(12):767-71.
    View in: PubMed
  629. Mukherjee D, Kalahasti V, Roffi M, Bhatt DL, Kapadia SR, Bajzer C, Reginelli J, Ziada KM, Hughes K, Yadav JS. Self-expanding stents for carotid interventions: comparison of nitinol versus stainless-steel stents. J Invasive Cardiol. 2001 Nov; 13(11):732-5.
    View in: PubMed
  630. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer C, Navarro F, Yadav JS. Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting. Am J Cardiol. 2001 Nov 1; 88(9):1064-6.
    View in: PubMed
  631. Kapadia SR, Bajzer CT, Ziada KM, Bhatt DL, Wazni OM, Silver MJ, Beven EG, Ouriel K, Yadav JS. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke. 2001 Oct; 32(10):2328-32.
    View in: PubMed
  632. Chew DP, Bhatt DL, Robbins MA, Mukherjee D, Roffi M, Schneider JP, Topol EJ, Ellis SG. Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. Am J Cardiol. 2001 Sep 15; 88(6):672-4.
    View in: PubMed
  633. Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, Topol EJ, Ellis SG. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation. 2001 Aug 28; 104(9):992-7.
    View in: PubMed
  634. Mukherjee D, Comella K, Bhatt DL, Roe MT, Patel V, Ellis SG. Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization. Am Heart J. 2001 Jul; 142(1):72-4.
    View in: PubMed
  635. Mukherjee D, Roffi M, Kapadia SR, Bhatt DL, Bajzer C, Ziada KM, Kalahasti V, Hughes K, Yadav JS. Percutaneous intervention for symptomatic vertebral artery stenosis using coronary stents. J Invasive Cardiol. 2001 May; 13(5):363-6.
    View in: PubMed
  636. Cho L, Bhatt DL, Wolski K, Lincoff M, Topol EJ, Moliterno DJ. Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT. Am Heart J. 2001 Apr; 141(4):599-602.
    View in: PubMed
  637. Chew DP, Bhatt DL, Lincoff AM, Moliterno DJ, Brener SJ, Wolski KE, Topol EJ. Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials. Circulation. 2001 Feb 20; 103(7):961-6.
    View in: PubMed
  638. Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation. 2001 Jan 23; 103(3):363-8.
    View in: PubMed
  639. Chew DP, Bhatt DL, Sapp S, Topol EJ. Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials. Circulation. 2001 Jan 16; 103(2):201-6.
    View in: PubMed
  640. Chew DP, Bhatt DL. Oral glycoprotein IIb/IIIa antagonists in coronary artery disease. Curr Cardiol Rep. 2001 Jan; 3(1):63-71.
    View in: PubMed
  641. Bhatt DL, Topol EJ. Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight. Curr Control Trials Cardiovasc Med. 2001; 2(6):260-262.
    View in: PubMed
  642. Chew DP, Bhatt DL, Topol EJ. Oral glycoprotein IIb/IIIa inhibitors: why don't they work? Am J Cardiovasc Drugs. 2001; 1(6):421-8.
    View in: PubMed
  643. Marso SP, Bhatt DL, Roe MT, Houghtaling PL, Labinaz M, Kleiman NS, Dyke C, Simmoons ML, Califf RM, Harrington RA, Topol EJ. Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators. Circulation. 2000 Dec 12; 102(24):2952-8.
    View in: PubMed
  644. Bhatt DL, Topol EJ. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA. 2000 Sep 27; 284(12):1549-58.
    View in: PubMed
  645. Roe MT, Harrington RA, Prosper DM, Pieper KS, Bhatt DL, Lincoff AM, Simoons ML, Akkerhuis M, Ohman EM, Kitt MM, Vahanian A, Ruzyllo W, Karsch K, Califf RM, Topol EJ. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation. 2000 Sep 5; 102(10):1101-6.
    View in: PubMed
  646. Cho L, Marso SP, Bhatt DL, Topol EJ. Optimizing percutaneous coronary revascularization in diabetic women: analysis from the EPISTENT trial. J Womens Health Gend Based Med. 2000 Sep; 9(7):741-6.
    View in: PubMed
  647. Bhatt DL, Ellis SG. Is the corrected TIMI frame count an independent predictor of adverse outcome? Circulation. 2000 Jul 11; 102(2):E19.
    View in: PubMed
  648. Cura FA, Bhatt DL, Lincoff AM, Kapadia SR, L'Allier PL, Ziada KM, Wolski KE, Moliterno DJ, Brener SJ, Ellis SG, Topol EJ. Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions. Circulation. 2000 Jul 4; 102(1):28-34.
    View in: PubMed
  649. Bhatt DL, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators. Am Heart J. 2000 Jul; 140(1):67-73.
    View in: PubMed
  650. Bhatt DL, Lincoff AM, Califf RM, Simoons ML, Tcheng JE, Brener SJ, Wolski KE, Topol EJ. The benefit of abciximab in percutaneous coronary revascularization is not device-specific. Am J Cardiol. 2000 May 1; 85(9):1060-4.
    View in: PubMed
  651. Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 2000 Mar 15; 35(4):922-8.
    View in: PubMed
  652. Bhatt DL, Topol EJ. Percutaneous coronary intervention for patients with prior bypass surgery: therapy in evolution. Am J Med. 2000 Feb; 108(2):176-7.
    View in: PubMed
  653. Bhatt DL, Topol EJ. Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease. Med Clin North Am. 2000 Jan; 84(1):163-79, ix.
    View in: PubMed
  654. Bhatt DL, Kapadia SR, Yadav JS, Topol EJ. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. Cerebrovasc Dis. 2000; 10 Suppl 5:34-40.
    View in: PubMed
  655. Marso SP, Lincoff AM, Ellis SG, Bhatt DL, Tanguay JF, Kleiman NS, Hammoud T, Booth JE, Sapp SK, Topol EJ. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation. 1999 Dec 21-28; 100(25):2477-84.
    View in: PubMed
  656. Bhatt DL, Ellis SG, Ivanc TB, Crowe T, Balazs E, Debowey D, Pangerl A, Chew PH. Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction. Am Heart J. 1999 Oct; 138(4 Pt 1):785-90.
    View in: PubMed
  657. Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis--how many patients might be eligible? Am J Cardiol. 1999 Sep 1; 84(5):598-600, A8.
    View in: PubMed
  658. Bhatt DL, Lincoff AM, Kereiakes DJ, Tcheng JE, Simoons ML, van der Wieken LR, Godfrey N, Califf RM, Topol EJ. Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention. Am J Cardiol. 1998 Nov 1; 82(9):1105-6, A6.
    View in: PubMed
  659. Bhatt DL, Gaylor DC, Lee RC. Rhabdomyolysis due to pulsed electric fields. Plast Reconstr Surg. 1990 Jul; 86(1):1-11.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Bhatt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_